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High-throughput DNA sequencing techniques have advanced rapidly in the past few 
decades. Sequencing technologies have been employed to address an increasingly diverse range 
of challenges in biology and medicine and have contributed to multiple significant discoveries in 
a variety of fields. This dissertation focuses on the design and synthesis of a set of novel 
disulfide linker based nucleotide reversible terminators (NRTs) that can be integrated into DNA 
sequencing by synthesis (SBS), the current dominant sequencing platform.  
The design and synthesis principles are outlined as follows. Four nucleotides (A, C, G, T) 
are modified as nucleotide reversible terminators for the DNA polymerase reaction by attaching 
a cleavable fluorophore to a specific location on the base and blocking the 3′-OH group with a 
small chemically reversible moiety so that the resulting molecules are still recognized by DNA 
polymerase as substrates. In these fluorescent NRTs, the fluorophores are attached through a 
disulfide (-SS-) cleavable linker to the 5-position of cytosine and thymine, and to the 7-position 
of deaza-adenine and deaza-guanine, and a small disulfide moiety is used to cap the 3'-OH group 
of the deoxyribose.  
The resulting fluorescent NRTs (3′-O-tert-butyldithiomethyl-dNTP-SS-fluorophore 
analogues) were shown to be good substrates in DNA polymerase catalyzed reactions. The 
fluorophore and the 3′-O-tert-butyldithiomethyl group on a DNA extension product, which is 
generated by incorporating the 3′-O-tert-butyldithiomethyl-dNTP-SS-fluorophore analogues in a 
polymerase reaction, are removed simultaneously and rapidly by treatment with a reducing 
agent, tris (3-hydroxypropyl) phosphine, in aqueous buffer solution. This one-step dual-cleavage 
reaction thus allows the reinitiation of the polymerase reaction and increases the SBS efficiency. 
DNA templates consisting of homopolymer regions were accurately sequenced by using this 
class of fluorescent nucleotide analogues on a DNA chip and a four-color fluorescent scanner. 
These experiments confirmed that the new set of nucleotide reversible terminators can be 
incorporated by polymerase with high efficiency; both its 3’ blocking moiety and the fluorescent 
tag can be chemically cleaved in one reaction, and the residue on the linker can self-collapse into 
a stable OH group, obviating a capping step.  
Chapter 1 reviews the development and history of DNA sequencing techniques, with the 
emphasis on the sequencing chemistry underlying each method. Chapter 2 delineates the design 
and synthesis of complete sets of the NRTs (3’-O-tert-butyldithiomethyl-dNTPs and 3’-O-tert-
butyldithiomethyl-dNTP-SS-Dye analogues). Chapter 3 describes the tests that have been 
conducted on this new set of NRTs, and discusses the way the new set of nucleotide analogues 
can be applied in sequencing by synthesis techniques.
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Chapter 1 Introduction to DNA Sequencing Techniques 
Deoxyribonucleic acid (DNA), is a polymeric biomolecule that plays a central role in all 
cellular life. It is the carrier of genetic information and determines the processes of development, 
physiology, and reproduction1. Obtaining DNA sequence is highly significant for fundamental 
biological and medical research. In particular, the individual genetic information precisely 
depicted by DNA sequencing techniques is laying the foundations for the modern advancement 
of personalized medicine, a paradigm that allows physicians to prescribe therapy based on 
individual circumstances such as their genetic traits instead of the population average, and is thus 
expected to revolutionize medical and therapeutic practice2. 
Due to the gigantic information content of DNA in the human genome and the high 
resemblance between its four building blocks, intensive efforts were required to obtain accurate 
DNA sequence. In the past few decades, we have witnessed a rapid advancement of sequencing 
techniques. Beginning with the epochal invention of the dideoxy sequencing method by Sanger, 
sequencing techniques have advanced dramatically. Next-generation, or short-read massively 
parallel sequencing methods significantly reduced the sequencing time and costs and currently 
dominate the sequencing applications. A variety of long-read single molecule sequencing 
techniques have been developed and have begun to successfully address certain irking challenges 
faced by next-generation sequencing techniques. DNA sequencing has moved from a laboratory 
luxury to a fundamental research tool. With DNA sequencing becoming continuously faster, 
cheaper and more accurate, applications of DNA sequencing are mushrooming and fields 
benefiting from DNA sequencing techniques are rapidly expanding. To date, sequencing 
techniques have been extensively applied in many areas, including genomics and genetics3-5, 
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epigenetics6, plant biology7, oncology8, microbial genomics9-10, epidemiology11, forensics12, 
agriculture13, diagnosis and therapy2, 14-16, and many more. 
This chapter will introduce DNA and DNA sequencing methods. The related biological 
and chemical concepts will be reviewed, and subsequently a brief introduction will be made to 
the existing sequencing techniques.  
1.1 Introduction to DNA Chemistry 
 
Figure 1-1 Chemical structure of 2’-deoxyribonucleoside 
triphosphate. Each molecule is composed of a five-carbon 
deoxyribose sugar, a triphosphate group, and a nitrogenous base. 
The four types of bases include two purine derivatives, adenine 




DNA is a polymeric biomolecule with a high molecular mass. It consists of four types of 
fundamental building blocks called nucleotides, each consisting of three components: a five-
carbon deoxyribose sugar, a phosphate group, and a nitrogenous base (adenine, cytosine, guanine 
or thymine).  The four bases can be divided into two categories, with adenine and guanine being 
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double ringed purine derivatives, and cytosine and thymine being single ringed pyrimidine 
derivatives (Figure 1-1).  
 
 
Figure 1-2  DNA structure. Two strands of complementary DNA 
are bound to each other and coiled into a double helical structure.  
The monomers of DNA connect to each other via phosphodiester 
bonds. Hydrogen bonds can form between an adenine and a 
thymine, or between a cytosine and a guanine, binding two 
complementary strands together. Figure was reproduced from Ref. 
17 with permission. 
 
DNA exists in biological organisms as two complementary strands bound tightly to each 
other.  As illustrated in Figure 1-2, deoxyribose and phosphate moieties constitute the external 
backbone of DNA, with a covalent phosphodiester bonds formed between the 5’-phosophate 
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group of one nucleotide and the 3’-hydroxyl group of another. Internal to the backbone are pairs 
of bases, the varying order of which defines the sequence of DNA. Hydrogen bonds can form 
between adenine-thymine or between cytosine-guanine base pairs. Through the hydrogen bonds, 
two complementary strands bind firmly together. They can further twist into a three-dimensional 
double helical structure.  
DNA has an ultra-high molecular weight. The human genome contains ~ 3 billion base 
pairs in total18. The large size of DNA endows it with a huge information storage capacity and 
permits it to serve as the hereditary material. 
1.2 Sequencing Techniques 
In this section, many of the major sequencing techniques will be reviewed. Sanger 
sequencing was the first sequencing method capable of obtaining DNA sequence on the scale of 
a whole human genome. Sequencing by synthesis based methods and sequencing by ligation 
based methods greatly increased sequencing throughput and reduced the time and costs involved. 
Nanopore based sequencing methods are single molecule techniques with unique advantages. In 
the interest of this thesis, the emphasis below is on the sequencing chemistry grounding each 
technique. 
1.2.1 Sanger Sequencing 
The so-called dideoxy sequencing method is a sequencing technique developed by 
Frederick Sanger and his coworkers19. It is also known as the chain termination method, as its 
key feature is the selective incorporation of chain-terminating nucleotides. The novelty of Sanger 
sequencing chemistry lies in the introduction of dideoxynucleoside triphosphates (ddNTPs). 
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ddNTPs (Figure 1-3) were the earliest nucleotide analogues synthesized to facilitate sequencing 
19-20. They resemble natural deoxynucleoside triphosphates (dNTPs) in every respect, except that 
they lack the 3’- hydroxyl group, which is critical for one nucleotide to form a phosphodiester 
bond with another. Consequently, when a ddNTP becomes incorporated in the middle of a 






Figure 1-3 Native dNTP (left) and ddNTP (right) used in 




In the early days of Sanger sequencing, in order to sequence a single-stranded DNA, four 
separate reactions needed to be conducted in parallel, each of which was analyzed in a separate 
lane of a polyacrylamide gel. Each reaction contains denatured DNA samples, primers, DNA 
polymerase, and all four native nucleotides, one of them radioactively labeled. To each of the 
four reactions is also added one type of ddNTP (ddATP, ddTTP, ddCTP, or ddGTP). The 
product sizes were determined by gel electrophoresis. 
Taking the ddATP channel for example, the DNA primer extension will proceed 
uniformly until an ‘T’ position in the template sequence, where the fates of extended chains split 
into two:  a small amount of DNA strands extended with ddATP will get terminated, as a result 
of missing a free 3’-OH group in the incorporated ddATP, whereas the remaining strands 
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incorporated with a natural dATP will continue to grow. The final mixture of extended DNAs 
truncated at various length will be size separated through gel electrophoresis. Radioautography is 
then used to reveal the relative positions of all bands. Observation of a band consisting of 
primers terminated by ddATP at a particular position indicates that at this position the template 
base identity is T. The same rule applies to C, G and T channels. In the end, sizing information 
from all four lanes can be gathered and combined to regenerate the complete sequence for the 
DNA sample. 
The labeling strategy and separation methods have been greatly improved: radioactive 
isotope was soon superseded by fluorescently labeled ddNTPs21-22 or fluorescently labeled 
primers23-27. Unlike isotopic labeling which provides limited binary information, fluorescent dyes 
can generate 4 distinct identification signals within a single reaction. In this way, four separate 
channels could be merged into one, which dramatically shortened the experiment time and 
reduced labor costs. Regarding separation methods, the capillary electrophoresis technique 
invented by Jorgenson and Lukacs28 supplanted slab gel electrophoresis29-31. With these 
techniques, automated large-scale Sanger sequencing was actualized32-33. 
Sanger sequencing dominated the sequencing industry for more than 20 years. It was the 
technique used in the Human Genome Project and still serves as the gold standard in many 
sequencing applications, such as de novo sequencing, targeted DNA sequencing, and validation 
of next-generation sequencing results. Nevertheless, Sanger sequencing is costly and relatively 




1.2.2 Sequencing by Synthesis Based Methods 
Sequencing by synthesis (SBS) based methods are approaches which use the unknown 
DNA strand as the template and reveal its sequence in the process of synthesizing a 
complementary strand with the aid of DNA polymerase. In this section, the polymerase will be 
first introduced as it plays a critical role in all SBS methods. Subsequently, several SBS methods 
will be discussed. In the interest of this thesis, sequencing by synthesis with fluorescent 
nucleotide reversible terminators (NRTs), one of the most influential and widely used modern 
sequencing techniques, will be discussed in detail. This is the method that best takes advantage 
of our novel cleavable fluorescent NRTs. 
Introduction to Polymerase and Its Influence on SBS Sequencing Chemistry 
DNA polymerases are a class of enzymes that can synthesize long chains of nucleic 
acids. They play a crucial role in all sequencing by synthesis applications. The polymerases 
utilized in SBS applications differ widely, ranging from Klenow polymerase, a proteolytic 
fragment of the native Escherichia coli DNA polymerase employed in early days in Sanger 
sequencing, to various commercialized polymerases engineered to accommodate different 
nucleotide analogues34. The availability of a compatible polymerase displaying high fidelity, 
processivity, and a desired speed is critical for the success of any sequencing chemistry to 
function.        
The catalytic activity of polymerase is inherent in its structure which resembles a right 
hand with three domains: palm, fingers, and thumb (Figure 1-4). The palm domain remains 
homologous among different polymerase families whereas the finger and thumb domains vary35. 
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During DNA synthesis, polymerase uses one strand of the DNA as the template, slides through 
the template from the 3’ to 5’ direction, and replicates it in the 5’ to 3’ direction.   
 
Figure 1-4 An exemplar of DNA polymerase structure. 
Illustration of the structure of Klenow fragment of E. coli DNA 
polymerase molecule determined by x-ray crystallography. The 
structure resembles a right hand in which the palm, fingers, and 
thumb grasp the DNA. Other DNA polymerases that replicate 
DNA have similar features. Figure was reproduced from Ref. 36 
with permission. 
 
The detailed mechanisms are described below: the three domains collectively form a cleft 
that the DNA template can bind to. The incoming nucleotide is selected by the next unpaired 
base of the template. The finger domain anchors the 3’-OH group of the extended template and 
positions it towards the incoming nucleotide. The highly conserved palm domain then recruits 
two metal ions (Mg2+ or Mn2+) to assist in the catalysis effect: one metal ion reduces the affinity 
of the hydrogen in the 3’-hydroxl group on the nucleotide of the extended primer, and aids the 
attack of the electron rich 3’-oxygen on the alpha phosphate of the incoming nucleotide; the 
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other metal ion coordinates the negative charge of the beta and gamma phosphates and facilitates 
the release of the pyrophosphate group. Once the hydrogen bonds between the base pair are 
formed, the finger domain will enclose the incoming nucleotide. The conformational alteration of 
the polymerase will stimulate the pyrophosphate group to leave, forming a new covalent 
phosphodiester bond between the extended strand and the incoming nucleotide. The polymerase 
then proceeds to attach the next nucleotide. 
 
 
Figure 1-5 Structure of active site of rate 𝜷 polymerase ternary 
complex. The primer is denoted in blue. The template is denoted in 
purple. The polymerase is denoted in yellow. And the incoming 
dideoxynucleoside triphosphate is denoted in green. Note the 
ample space on the base and the limited space at the 3’ position on 
the sugar. For this reason, polymerase tends to be highly intolerant 
to bulky modifications on the 3’-hydroxyl group of a nucleoside 
triphosphate. Figure was adapted from Ref. 37 with permission. 
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Polymerase tends to be highly intolerant to bulky modifications on the 3’-hydroxyl group 
of a nucleotide38. This feature has significantly impacted the design of nucleotide analogues in 
most sequencing chemistries, exerting a stringent constraint on the size of the moiety that can be 
attached to the 3’-hydroxyl group, and rendering it much more difficult to use nucleotide 
analogues with large groups attached to the 3’ position as reversible terminators. 
Pyrosequencing Based Sequencing Techniques 
Pyrosequencing was the first commercialized massively parallel DNA sequencing by 
synthesis technique. In 1988 Hyman first proposed that the pyrophosphates generated by the 
DNA polymerization reaction can be measured to infer sequence information39. Later Nyrén and 
Ronaghi developed a pyrosequencing chemistry that does not require electrophoresis, 
radioactivity or fluorescence40-42. Combining this sequencing chemistry with the emulsion PCR 
technique, in 2000 Rothberg and coworkers founded 454 Life Sciences, where they utilize 
microfabricated reactors and charge-coupled devices (CCD) sensors to conduct sequencing on a 
large scale43. 
The sequencing workflow is described below. After library preparation and emulsion 
PCR amplification, millions of beads, each containing a large amount of clonally amplified 
single-stranded DNA fragments, are collected. Each bead is inserted into a picoliter-scale well 
within a flow chamber, where local light signals can be monitored by a CCD camera. The 
sequencing chemistry is illustrated in Figure 1-6. Substrates (luciferin, adenosine 5’-
phosphosulfate), together with one of the four types of native nucleotides, flow through the 
chambers in turn. Whenever the correct complementary nucleotides get incorporated, myriads of 
pyrophosphates will be released simultaneously from the amplified clone. Sulfurylase can 
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convert the released pyrophosphates into ATP, which can then be converted into light by 
luciferase in the presence of luciferin. In this way, when a CCD camera captures a light signal, it 
indicates the currently added nucleotide is complementary to the base to be sequenced. After 
identification of the base in each cycle, the unreacted dNTPs are degraded by apyrase and the 
next cycle begins. The sequence will be obtained during the synthesis. 
 
 
Figure 1-6 Principle and reaction cascade of pyrosequencing. 
Incorporation of correct nucleotides triggers the release of a 
synchronized wave of pyrophosphates from the extended templates 
within a clonal island. This can then be translated into a light 
signal through the enzymatic cascade shown, revealing the base 
identity. Figure was reproduced from Ref. 44 with permission. 
 
Since pyrosequencing chemistry doesn’t prevent multiple additions, it is difficult for this 
method to extract the exact number of identical consecutive nucleotides, all of which will be 
synthesized in the same cycle, releasing an amalgamated light signal theoretically linear to the 
nucleotide number but practically hard to interpret. As a consequence, this method 
unsurprisingly had a high error rate in homopolymeric regions with additions and deletions 
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constituting the dominant errors45-46. This challenge can be easily resolved if the sequencing can 
be forced into a strict one-step-per-cycle process47 
Ion Torrent, a platform developed by Ion Torrent Systems Inc., utilizes a similar 
chemistry to conduct sequencing48. In this method, an integrated complementary metal oxide 
semiconductor and an ion-sensitive field-effect transistor is used to measure the pH alteration 
induced by the release of H+ ions accompanying the incorporation of a type of dNTP. This 
method successfully uses semiconductor manufacturing techniques to evade the complicated 
enzymatic cascade in the original pyrosequencing method; however, as no capping moiety exists 
to prevent addition of more than one nucleoside, it shares the same problems when sequencing 
homopolymeric regions49. 
Sequencing by Synthesis with Fluorescent Reversible Terminators 
Prior to 2000, the use of fluorescent nucleotide reversible terminators (NRTs) for SBS 
that had a fluorescent dye attached to the 3’-OH of the nucleotide through a cleavable linker was 
investigated extensively by numerous groups without success50,51. The Ju group was the first to 
successfully design and synthesize a full set of fluorescent NRTs that were accepted by DNA 
polymerase as substrates and proved the feasibility of the principle52. A commercial application 
implementing the SBS chemistry was launched53, which led to a plummet in sequencing costs. 
Currently, sequencing by synthesis with fluorescent NRTs is the dominant commercial 
sequencing method54.  
In this method, the DNA sample is first fragmented and amplified, with adapters added to 
the end of the amplified DNA sample fragments55. DNA primers complementary to the adapter 
sequence are added. Polymerases will extend the primers and the unknown sequence of each 
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fragment is revealed during the synthesis of the new complementary strand. High power 
computation is then required to assemble the fragmented sequences to reconstruct the complete 
sequence of the original DNA sample. 
In this method, reversible terminators are designed to replace native nucleotides as 
substrates for polymerase. The reversible terminators are usually nucleotide analogues with a 
cleavable blocking moiety capping the 3’-OH group and a fluorescent dye tethered to the base 
via a cleavable linker. This design is to guarantee good incorporation by polymerase as well as a 
strict one-addition-per-cycle sequencing pattern, to facilitate a highly synchronized behavior 
among local clonally amplified templates in the sequencing process. 
The detailed sequencing chemistry is illustrated in Figure 1-7 using 3’-O-allyl-dNTP-
allyl-fluorophore analogues as an example52. After template immobilization, polymerase and a 
mixture of four-color modified nucleotides are flowed over immobilized templates and primers. 
Due to the presence of a blocking moiety on the 3’-OH group, only one nucleotide can be added 
to a template in each incorporation cycle. The fluorescent signal, weak for each individual 
molecule but collectively strong, will yield a high signal-to-noise ratio and can be measured to 
determine the base identity. After the fluorescence data are collected, the blocking moiety and 
the fluorescent tag are chemically cleaved under mild conditions. Detached fragments as well as 
unreacted nucleotides are washed away, and the next cycle of extension can resume and 
sequencing proceed. In this manner, the sequence is revealed during the synthesis process. 
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Figure 1-7 Four-color sequencing by synthesis method on a 
DNA chip. (A) Reaction scheme of sequencing by synthesis using 
four color cleavable fluorescent reversible terminators. (B) 
Fluorescence scanned images after each reaction. (C) Plot of raw 
fluorescence emission intensity at the four emission channels for 
each of the four cleavable fluorescent nucleotides after each 
extension and cleavage reaction. Figure was reproduced from Ref. 
52 with permission. 
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The soul of developing a fast, cheap and accurate SBS system with reversible terminators 
lies in the development of a set of reversible terminators, with the following features: they should 
be able to prevent polymerase from adding more than one nucleotide at a time; they should 
contain distinguishing labels; they should be incorporated by polymerase with desirable speed 
and high fidelity; and the blocking moieties and the label should be cleavable under conditions 
innocuous to the DNA templates.  
 
In the past, Ju and other groups have reported the successful design and synthesis of 
several sets of fluorescent and non-fluorescent cleavable nucleotide reversible terminators.  3’-O-
allyl-dNTP-allyl-fluorophore molecules (Figure 1-8) represent an exemplary set of fluorescent 
NRTs52, 56. The 3’-OH group is capped by an allyl moiety and four distinct fluorescent tags are 
tethered to four corresponding bases via an allyl based linker. The fluorescent NRTs can be 
incorporated by polymerase, and both the capping moiety and the linker can be simultaneously 
cleaved by Pd-catalyzed deallylation in aqueous solution, regenerating the 3’-OH group for the 
next cycle of sequencing. 
 




























3’-O-PC-dNTP-PC-fluorophore compounds (Figure 1-9) are another set of nucleotide 
analogues that function as fluorescent NRTs57. The 3’-OH group is capped by a 2-nitrobenzyl 
moiety and four distinct fluorescent tags are tethered to the four bases via a nitrobenzyl based 
linker. The unique advantages of these nucleotide analogues is that both the capping moiety and 
the linker can be cleaved by photo irradiation. However, the 2-nitrobenzyl group is bulky, and 
incorporation by polymerase is not efficient. 
 
 




3’-O-azidomethyl nucleotide analogues are another set of fluorescent reversible 
terminators that have been used for SBS58-60. The 3’-OH group is capped by an azidomethyl 
moiety and distinct fluorescent tags are tethered to the four bases via an azido based linker. Both 
the capping moiety and the linker can be simultaneously cleaved in 100 mM tris(2- 


























Figure 1-10 An example of a fluorescent azidomethyl-based 
nucleotide reversible terminator60 
 
The Engels group used a 2-cyanoethoxy or 2-cyanoethyl moiety to cap the 3’-OH 
group61-62. Four different fluorescent tags are tethered to the four bases via a cyanoalkyl based 
linker. The fluorescent reversible terminators can be incorporated by polymerase. The 3’ 
blocking moieties as well as the linker can be cleaved when treated with 1:1 solution of THF and 
DMF which contains 0.5 M TBAF at 45 oC for 15 min. 
 
 
Figure 1-11 An example of a fluorescent 3’-O-cyanoethyl 
nucleotide reversible terminator61-62.  
 
The Benner group developed a set of fluorescent reversible terminators with an 
aminoalkoxyl group at the 3’ position and a fluorescent tag attached to the base via a diol 

























































the fluorescent tag. The 3’-O-NH2 group can be cleaved by 700 mM nitrous acid (pH 5.5), with 




Figure 1-12 An example of a 3’-O-NH2 based nucleotide reversible terminator 63. 
Compared with pyrosequencing, sequencing by synthesis with fluorescent NRTs 
perfectly resolves the sequencing difficulties in homopolymeric regions by introducing a 
cleavable capping moiety at the 3’-hydroxyl group. Other advantages include high throughput, 
low cost per base and short processing time which contribute to its success as the most widely 
used massively parallel DNA sequencing technique. However, as is true for other massively 
parallel DNA sequencing methods, obtaining signals from amplified clones faces the challenge 
of synchronization. Individual template missteps in each cycle will gradually accumulate and 
diminish the signal-to-noise ratio, leading to a short read length (50-300 bp), limiting its 
application in de novo sequencing and studies on structural variants.  
Single Molecule Sequencing by Synthesis with Virtual Terminators 
 Single molecule sequencing methods are sequencing techniques that do not involve PCR 

































synchronization problems caused by dephasing of extension reactions for different templates 
within one amplified local clone, a common challenge faced by massively parallel sequencing 
methods. In addition, because they do not involve growing a cluster of target DNA fragments, 
PCR-introduced errors and biases are prevented, and any in vivo DNA modification information 
which otherwise would be lost in the amplification process can be easily preserved.   
 The feasibility of single molecule sequencing was first demonstrated by Quake and 
colleagues in 200364. In 2007 Helicos Biosciences launched the first single-molecule sequencer 
based on this work. The sequencing is conducted in a manner similar to sequencing by synthesis 
with fluorescent reversible terminators. Total internal reflection fluorescence microscopy (TIRF) 
is employed to achieve single molecule resolution.  
 The complete workflow is described below. The DNA sample is first fragmented and 
tethered to a polyadenine tail, whose last adenine is fluorescently labeled. The fragments then 
flow over a surface on which multiple polythymine oligonucleotides are covalently attached. 
Fragments are captured by hybridization. Cycles of sequencing by synthesis with virtual 
terminators are then conducted in a manner similar to those mentioned previously. 
 The sequencing chemistry employs nucleotide analogues called virtual terminators 
developed by Bowers et al65. An example of a virtual terminator can be found in Figure 1-13. 
The design included an unblocked 3’–OH to facilitate the incorporation by polymerase. As both 
the inhibiting group and the fluorescent tag are located on the base, they obviously can be 
removed with a single cleavage. The terminating effect, presumably due to the steric hindrance 
of the bulky group tethered on the base, has been verified experimentally65-67. Nevertheless, 
failures to prevent multiple addition does occur and the resulting deletion errors are the most 
common error type for this method68.   
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Figure 1-13 An example of a virtual terminator. The fluorescent 
tag as well as the inhibiting group can be removed by the cleavage 
of a single bond.  
 
 Sequencing by synthesis with virtual terminators was the first single molecule sequencing 
method successfully launched into the market. It confirmed the feasibility of the single molecule 
sequencing method. However, the drawbacks it inherited from massively parallel sequencing by 
synthesis methods, e.g. short read lengths, long run times, along with its inherent high raw error 
rate, have largely limited its application69. 
Single Molecule Real-Time Sequencing 
  Single molecule real-time sequencing (SMRT) is a technique developed by Pacific 
Biosciences70. The zero-mode waveguide (ZMW), a nanophotonic 100nm-diameter well lit from 
the bottom (Figure 1-14 A), is utilized to facilitate sequencing. When light from the excitation 
beam passes through a ZMW, it decays exponentially due to its relatively large wavelength, and 
only the bottom 20-30 nm of the ZMW can be illuminated and observed. At the bottom of each 
ZMW is immobilized a single polymerase, which can recognize and incorporate nucleotide 
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analogues complementary to the base on the template. During the incorporation process, the 
polymerase will retain the incoming nucleotide analogue together with its tethered dye in the 
detection volume for a period three orders of magnitude longer than the cleaved dye fragments or 
other unincorporated nucleotides, resulting in a high signal-to-noise ratio. A time series of 
fluorescence signals can reveal the sequence of a template DNA strand (Figure 1-14 B). 
 The nucleotide analogues used in the single-molecule real-time sequencing technique are 
phospholinked nucleotide analogues (Figure 1-15). Unlike the majority of nucleotide analogues 
used in next-generation sequencing methods, which have dyes tethered to the base, these have 
the fluorescent dye linked to the triphosphate group. After being incorporated by polymerase, the 
phosphate chain will be cleaved and the dye will be released and diffuse away, leaving a native 
nucleotide on the growing strand.   
 
 
Figure 1-14 Single molecule real-time sequencing technique. 
(A) A zero-mode waveguide. (B) Incoming nucleotide analogue 
retained by polymerase generates a longer signal, differentiating it 
from the surrounding free nucleotides and cleaved dyes. Figure 







Figure 1-15 Phospholinked nucleotide analogues used in the 
single molecule real-time sequencing technique70. Fluorescent 
dye is linked to the triphosphate group. 
 
 
As a single molecule sequencing technique, the SMRT technique successfully avoided 
the problems introduced by PCR amplification. Besides, with no concerns of dephasing and its 
use of a highly processive enzyme, SMRT sequencing has a major advantage in its long read 
length, which can reach over 10 kbp on average. Its remarkable long read length makes this 
sequencing technique highly valuable for sequencing highly repetitive regions. The drawbacks of 
SMRT are its relatively low throughput and high error rate71.   
1.2.3 Sequencing by Ligation Based Methods 
DNA ligase is an enzyme that catalyzes the formation of covalent phosphodiester bonds 































Figure 1-16 Di base oligonucleotide probes73. Two specific bases 
followed by three degenerate bases (n), linked to another three 
degenerate bases (z) via a cleavable site. A fluorescent tag is 
attached at the end. Each fluorescent label is associated with four 
possible instances of the first and second base combinations. 
 
The sequencing by oligonucleotide ligation and detection (SOLiD) system is a 
sequencing by ligation based platform commercialized by Applied Biosystems74. It was built 
based on the polony sequencing method developed by George Church’s group75. Since two 
consecutive bases can have 16 combinations, 16 corresponding oligonucleotide probes were 
constructed. Each oligonucleotide probe is eight bases in length, with the first and the second 
bases complementary to the two bases at the probing site and the third to fifth bases degenerate, 
capable of pairing with any nucleotide combinations. Between the fifth and the sixth nucleotide 
exists a cleavage site. The last three bases are also degenerate and have a fluorescent tag attached 
at their termini. Four fluorescent dyes are used, each corresponding to four possible two-base 
combinations. 
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The workflow of SOLiD is described as follows. DNA samples are fragmented and 
amplified by emulsion PCR to generate millions of beads, each containing numerous identical 
copies of a short fragment of the original DNA. The beads are then covalently attached to a glass 
slide in preparation for the ligation chemistry and imaging.  Each template DNA fragment is 
annealed to an adapter sequence. Primers complementary to the adapter sequence are first added 
and become hybridized. Subsequently, cycles consisting of ligation, detection and cleavage are 
performed repeatedly. In each cycle, the mixture of all 8-mer probes are added. Only the probes 
with both 1st and 2nd bases complementary to the unknown sequence can hybridize to the 
template sequence and be ligated. The fluorescence is measured and recorded, followed by 
cleaving between the 5th and 6th nucleotides to remove the last three bases and the fluorescent 
tag. As the 5’-phosphate group is re-exposed, the next cycle can resume. After seven or more 
cycles of sequencing, the synthesized strands are removed. A new primer offset by one base is 
employed and another sequencing round can start. Due to the three-base sequencing gap between 
each sequencing cycle and the limited information content of each fluorescent label, a total of 5 
rounds of such cyclic probing is required. Eventually, the information in color space is 
deconvoluted into nucleotide space to reveal the sequence73. 
Another example of the sequencing-by-ligation technique is the combinatorial probe-
anchor ligation (cPAL) approach employed by Complete Genomics76 . In a cPAL workflow, 
DNA is first fragmented into average 500 base pair long pieces. Fragmented DNAs are ligated to 
four unique adapter sequences and undergo rolling circle amplification. As the adapters contain 
palindromic sequences, the released circular template will self-assemble into a tight ball of DNA. 
The DNA nanoballs are then deposited on an array to produce dense active spots. Each spot 




Figure 1-17 Principle of combinatorial probe-anchor ligation 
(cPAL). Probes (middle) specific at one position and degenerate at 
the rest are constructed. Measurement is repeated in two rounds. 
The first round (left) probes the 1-5 position of the sequence and 
the second round (right) probes the 6-10 position. In each round, 5 
cycles of hybridization, imaging and removal of primer-anchor 
complex are repeated. Figure was reproduced from Ref. 76 with 
permission. 
 
A set of probes is constructed, each starting with an anchoring sequence complementary 
to a fragment adapter, followed by ten or fifteen bases specific at one position and degenerate at 
the rest, and an identifying fluorescent tag at the end. Sequencing proceeds in two rounds. In the 
first cycle of the first round, standard anchors complementary to one type of the four adapters are 
added, serving as primers. Only the probe with the correct match at the first position will get 
ligated and its fluorescent signal recorded. The primer-anchor complex is then removed, and 
anchors whose probing site is shifted by one position are added for the next cycle. The procedure 
repeats until all five positions are probed. Then standard anchors are replaced by anchors with 
five degenerate offset bases. The second round includes five more cycles to sequence the bases at 
the 6th - 10th positions. The same process is repeated for the other three adapters within the 
circular template.  
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Sequencing by ligation methods have a high accuracy and a low cost per base. However, 
compared with other sequencing methods, the short length of reads generated from these 
methods limit their application for genome assembly and structural variant detection54. 
1.2.4 Nanopore Based DNA Sequencing Methods 
 Nanopore sequencing is a single molecule sequencing approach that has drawn a lot of 
attention in recent years77-79. A biological or solid-state pore can be embedded into a membrane 
to facilitate sequencing. 
 
  
Figure 1-18 Dimensional information of commonly studied 
biological nanopores. (a) 𝛼-HL pore with a 1.4 nm constriction 
zone. The 𝛽-barrel is 2.6 nm in width and 5 nm in length and can 
accommodate ~10 nucleotides. (b) MspA nanopore with a 1.2 nm 
constriction area. The narrow channel at the exit is only ~0.5 nm 
long. Both nanopores only permit the passage of a single strand of 
DNA. Figure was reproduced from Ref. 77 with permission. 
 
 Biological pores were the first studied candidates for nanopore sequencing. Several 
biological pores have been successfully applied to conduct sequencing and the key dimensions of 
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two of them are illustrated in Figure 1-18. Alpha-hemolysin (𝛼-HL), a mushroom-like 
heptameric exotoxin secreted by the bacterium Staphylococcus aureus, was the earliest 
investigated pore80-82 . It was used in the proof of principle experiment for nanopore 
sequencing83, and has been successfully engineered and applied to conduct single nucleotide 
sequencing84. Mycobacterium smegmatis porin A (MspA), a funnel-like octameric porin from  
Mycobacterium smegmatis , is another compelling candidate85. MspA is highly stable86 and has a 
shorter constriction area compared with 𝛼-HL87, allowing its blockade signature to reflect more 
an individual blocking effect than an averaged one88. The engineered MspA has been 
demonstrated to have the capability to distinguish single nucleotides in ssDNA89. Polymerase 
phi29 can be engineered to form complexes with DNA, serving as a motor protein that slows 
down and controls the translocation of ssDNA through the pore in order to enhance accuracy90-91.  
Other nanopores that have been investigated for nanopore sensing include Aerolysin (AeL), a 
funnel-like heptameric pore from Aeromonas hydrophila92, outer membrane protein G (OmpG), 
a monomeric 𝛽-barrel protein93,  and CsgG,  a crown-shaped nonameric membrane protein 
derived from Escherichia coli94-95.   
 Solid state nanopores are nanometer scale holes formed within a synthetic membrane. 
Artificial nanopores made of Si3N496, SiO297, and Al2O398 have been fabricated and tested. 
Single-layer materials including graphene, BN99 and MoS2100 have also been investigated. 
Compared with biological nanopores, solid state nanopores have better chemical, mechanical and 
thermal stability and potentially can be mass produced at a cheaper cost. However, they lack the 
atomic scale reproducibility and cannot be as easily engineered as biological pores.  It is 
especially challenging for solid state nanopores to discriminate molecules with similar size yet 
different chemical specificity. Attempts have been made to combine the advantages of biological 
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and solid state nanopores to form a hybrid system101. Nevertheless, to date no solid-state or 
hybrid nanopores have been reported as a successful sequencing platform. 
 
  
Figure 1-19 Principle of Oxford nanopore sequencing. (a) Ionic 
solution filled chambers separated by a voltage-biased membrane. 
A single strand of DNA (black) is electrophoretically driven 
through the nanopore (green) under the modulation of an enzyme 
(red). (b) Current measurement by an ammeter accompanying the 
single strand DNA being translocated through the pore. Figure was 
reproduced from Ref. 78 with permission. 
 
 The MinION nanopore sequencing platform developed by Oxford Nanopore Technologies 
can sequence fragments with lengths over 100kb. Voltage is applied across the membrane, 
generating an ion current that electrophoreses DNA through the pore. The pore has nanoscale 
structural precision, only permitting single stranded DNA to pass through. Whenever a base 
approaches the constricted bottleneck region within the inner tunnel, its blocking effect will 
induce a measureable current disturbance with a signature unique to its own steric and electronic 
composition. A time series analysis of current levels can decode the identities of nucleotides that 
pass through the pore and reveal the DNA sequence.  Besides applications of  DNA sequencing, 
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the nanopore technique can also be used to directly detect DNA modification, as the electrical 
signature of modified nucleotides was found to be different from unmodified ones102. The 
sequencing instrument is portable and data can be acquired and analyzed rapidly, making this 
technique highly convenient, especially for clinical applications. Nevertheless, platform and data 
analysis methods need to be improved to resolve the current high error rate resulting from the 
high translation speed and low signal sensitivity intrinsic to this technique103-104. 
 
Figure 1-20 Principle of Genia nanopore sequencing. During 
the polymerase reaction, a ternary complex forms, positioning the 
distinct oligonucleotide-based tag into the nanopore and inducing a 
current blockade signature. Time series analysis of current signals 
will reveal the DNA sequence. Figure was reproduced from Ref. 
105 with permission. 
 
 The sequencing approach developed by the Ju group at Columbia University and Genia 
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Technologies utilizes the nanopore based sequencing by synthesis strategy to conduct DNA 
sequencing105-107. In this method, an 𝛼-HL pore, embedded in a lipid bilayer, is conjugated to a 
DNA polymerase. Each of the four nucleotides is attached to a distinct oligonucleotide-based 
tag. During the DNA polymerase reaction, the incoming nucleotide forms a ternary complex 
with the template/primer and the polymerase, and the tag enters into the nanopore, producing a 
current blockade signature. The sequence will be revealed in the process of synthesizing a 
complementary strand of the target DNA by analyzing the time series of the electrical signals. 
This method should have a high accuracy with further optimization105.  
1.3 Summary 
In this chapter, I reviewed the major DNA sequencing techniques, including Sanger 
sequencing, sequencing by ligation based sequencing methods, sequencing by synthesis based 
sequencing methods, and nanopore based sequencing methods.  
Scientists have come to a consensus on the importance of obtaining DNA sequence. Even 
back in the days when the only easily automatable sequencing method was the expensive and 
laborious Sanger sequencing approach, scientists throughout the world collaborated in the 
Human Genome Project for 13 years to obtain the sequence of the human genome and the map 
of the human genes18. 
Sequencing by synthesis based techniques, especially sequencing by synthesis with 
fluorescent reversible terminators, have contributed to a significant reduction in sequencing time 
and a plummet in sequencing costs54.  It took more than 10 years and an estimated $300 million 
worldwide to generate the first human reference genome in the Human Genome Project, whereas 
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nowadays the cost to generate a human genome sequence has dropped below $1500 (Figure 
1-21), and it can be accomplished in several days54.  
 
Figure 1-21 Reduction in sequencing costs in the last 20 years. 
Figure was reproduced from Ref. 108 with permission. 
 
With sequencing becoming more affordable, the demand for human genome sequencing 
is rocketing. In particular, with the advancement of precision medicine, multiple projects are 
ongoing in various countries worldwide, e.g., the Precision Medicine Initiative hosted by the 
National Institutes of Health in the USA, targeting 1 million volunteers109,  the 100,000 Genomes 
Project hosted by the UK Department of Health targeting 100,000 genomes110, Genome Korea in 
Ulsan Project hosted by the Ulsan National Institute of Science and Technology (UNIST) 
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targeting the genomes of 10,000 Korean individuals, and the 15-year precision medicine 
initiative of China with a $9.2 billion fund111.  
In an era when several human reference genomes are readily available and accessible, 
and the primary concerns for most individual human genome sequencing applications are speed, 
cost and accuracy, sequencing by synthesis with fluorescent reversible terminators has found its 
niche and won a dominant position in the market. Therefore, although single molecule and 
nanopore based sequencing methods have unique advantages in long read length, low 
amplification-related bias, and in some cases portability, with the soaring growth of demand for 
individual human genome sequencing, SBS with fluorescent reversible terminators is expected to 
continue playing a role as one of the most important and widely used sequencing techniques54. 
In this thesis, we develop a set of novel disulfide linker based nucleotides as promising 
fluorescent reversible terminators for sequencing by synthesis applications. Compared with 
existing fluorescent NRTs, the unique disulfide linkers used to synthesize the NRTs described in 
this thesis are cleaved efficiently umder DNA compatible conditions, leading to shorter scars on 
the DNA extension strand to facilitate longer reads and further improvement of the DNA SBS 
technology. In the following sections, the design and synthesis of the newly developed set of 
nucleotide analogues and the experimental proof that they possess desirable characteristics as 
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Chapter 2 Design and Synthesis of 3’-O-tert-Butyldithiomethyl-dNTP and 3’-
O-tert-Butyldithiomethyl-dNTP-SS-Dye for DNA Sequencing by Synthesis 
2.1 Introduction 
DNA sequencing, a critical tool for biological and medical research, has advanced rapidly 
in the last few decades. Many sequencing methods have been proposed and implemented. One of 
the most important among them is sequencing by synthesis (SBS) with fluorescent reversible 
terminators, which currently dominates the sequencing market.  
The currently widely applied high-throughput SBS methods utilize cleavable fluorescent 
nucleotide reversible terminator (NRT) chemistries such as those previously developed by the Ju 
group1-2. In this paradigm, distinct fluorescent tags are attached to the 5-position of the pyrimidines 
(T and C) and 7-position of the purines (A and G) to serve as reporting groups. A small moiety is 
also attached to the 3’-O-position of the sugar to temporarily endow the nucleotide the 
characteristic of a terminator, preventing multiple incorporation events in one cycle; this especially 
enhances the read accuracy in homopolymeric regions. As mentioned previously, some engineered 
polymerases have demonstrated a high tolerance for nucleotide analogues modified in the 
aforementioned pattern. The NRTs can be recognized as substrates by these polymerases and be 
successfully incorporated to facilitate sequencing by synthesis. After fluorescence measurement 
for base identification, the tag as well as the 3’ capping moiety can be cleaved by adding chemical 
reagents. The next cycle of sequencing is then ready to resume. 
Multiple sets of fluorescent reversible terminators have been developed, as previously 
described. Nevertheless, fluorescent NRTs with faster cleavage, higher enzymatic incorporation 
speed, high fidelity, and a shorter cleavage residue on the base are always desirable. In this work, 
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we develop a set of novel disulfide linker based fluorescent reversible terminators for sequencing 
by synthesis applications. Each of the fluorescent NRTs contains a 3’-O-tert-butyldithiomethyl 
(DTM) group and a distinct fluorescent tag connected to the base via a DTM linker. 
The tert-butyldithiomethyl group has been reported as a blocking moiety for hydroxyl 
groups within nucleosides before3-5, though there are no publications demonstrating their 





Figure 2-1  Comparison between previously employed 
disulfide linkers (A) and the O-dithiomethy linker 
employed in this work (B). The cleavage product of 
traditional disulfide linkers will require a further capping 
step whereas the cleavage product of an O-dithiomethyl  
linker can self-collapse into a relatively stable hydroxyl 
group, obviating a capping step. 
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Cleavable disulfide linkers have been used to tether fluorescent tags to the base6-7; 
however, in previous designs, a reactive SH group will be left after the cleavage (Figure 2-1 A), 
demanding an extra capping step and leaving a bulky residue that interferes with further 
incorporation.  In our design, the O-DTM linker can be cleaved in an aqueous buffer solution, 
resulting in a SH residue on the R group, which can intrinsically self-collapse into a stable OH 
group, leading to no need for a subsequent capping step (Figure 2-1 B). The cleavage reagent 
can be either tris(3-hydroxypropyl)phosphine (THP) or tris(2-carboxyethyl)phosphine (TCEP), 
which are soluble in aqueous solution and cause no damage to DNA (Figure 2-2). 
 
Figure 2-2  Cleavage reagent tris(2-carboxyethyl)phosphine 
(TCEP) (left) and tris (3-hydroxypropyl) phosphine (THP) (right) 
 
In this thesis, novel reversible terminators in which a small DTM moiety is attached to 
the 3’-OH position and four distinct fluorescent tags are attached via a DTM linker to the 5-
position of the pyrimidine bases or 7-position of the purine bases are designed and synthesized 
(Figure 2-3). A set of the non-labeled reversible terminators are also designed and synthesized to 
serve as a chasing nucleotide in SBS (Figure 2-4). These novel reversible terminators can be 
effectively incorporated by DNA polymerase. Both the linker and the protecting group can be 
cleaved with tris (3-hydroxypropyl) phosphine (THP) in aqueous buffer solution in a single step, 
and the thiomethyl residue on both the 3’-O position and the base can self-collapse into a stable 
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OH group such that the 3’ position is ready for the next incoming nucleoside triphosphate 
incorporation, and there is no need for a subsequent -SH capping step. 
 
 
Figure 2-3  Structure of 3’-O-tert-butyldithiomethyl-dNTP-SS-
Dye compounds. The 3’-OH of each nucleoside triphosphate is 
capped with a tert-butyldithiomethyl (DTM) group. A distinct 







Figure 2-4  Structure of 3’-O-tert-butyldithiomethyl-dNTPs. 
The 3’-OH of the nucleoside triphosphate is capped with a tert-
butyldithiomethyl (DTM) group. 
 
The novel set of reversible terminators can be applied in DNA sequencing by synthesis 
applications as illustrated in Scheme 2-1. The sequencing is conducted in cycles. In each cycle, a 
mixture of 3’-O-tert-butyldithiomethyl-dNTP-SS-Dye compounds will be added. Each extended 
primer will be incorporated with only one nucleotide analogue, the one complementary to the 
template, due to the existence of the capping moiety on the 3’-OH group. After washing, the 
fluorescent signal will be measured to determine the nucleotide identity. A synchronization 
reaction mixture consisting of 3’-O-tert-butyldithiomethyl-dNTPs, reversible terminators with 
higher polymerase incorporation efficiency, will then be added to extend any remaining priming 
strand that still has a free 3’-OH group. Subsequently, TCEP or THP solution can be used to 
cleave both the fluorophore and the 3’-DTM group, regenerating the free 3’-OH group. After 
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washing, the next cycle of sequencing can resume. The same procedure can be repeated and the 
sequence will be revealed in the process of synthesis. 
 
Scheme 2-1  Utilization of 3’-O-tert-butyldithiomethyl-dNTP-SS-
Dye compounds for sequencing by synthesis applications.   
 
The overall synthetic route and the key mechanisms are explained in section 2.2. The 
synthesis procedure is described in section 2.3 for 3’-O-tert-butyldithiomethyl-dNTPs (3’-O-tert-
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butyldithiomethyl-dATP, 3’-O-tert-butyldithiomethyl-dCTP, 3’-O-tert-butyldithiomethyl-dGTP 
and 3’-O-tert-butyldithiomethyl-dTTP) and section 2.4 for 3’-O-tert-butyldithiomethyl-dNTP-
SS-Dye compounds (3’-O-tert-butyldithiomethyl-dATP-7-SS-ROX, 3’-O-tert-
butyldithiomethyl-dCTP-5-SS-Alexa488, 3’-O-tert-butyldithiomethyl-dGTP-7-SS-Cy5 and 3’-
O-tert-butyldithiomethyl-dUTP-5-SS-R6G). 
2.2 Overall Synthetic Route  
 
Scheme 2-2  Overall scheme of synthesis of 3’-O-tert-
butyldithiomethyl-dNTP-SS-Dye analogues. Detailed conditions 
are introduced in the subsequent sessions. 
 
The overall synthetic scheme is illustrated in Scheme 2-2. A nucleoside with both the 5’-
OH and exocyclic amine on the base protected was treated with acetic acid, acetic anhydride and 
DMSO to introduce a methylthiomethyl group at the 3’-OH position. The methylthiomethyl 
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dithiomethyl linker was attached to the base via Sonogashira coupling. The protecting group on 
the 5’-OH group was then removed, and the nucleoside was triphosphorylated. Finally, the dye 
was added to the nucleoside triphosophate. The key steps are discussed subsequently in detail in 
the following sections. 
2.2.1 Introduction of Methylthiomethyl Group with Modified Pummerer’s 
Rearrangement Reaction 
The methylthiomethyl group on the 3’-OH group of the NRTs was introduced by a 
modified Pummerer’s rearrangement reaction. The mechanism has been studied by Johnson and 
Phillip8, and is illustrated in Scheme 2-3. The nucleoside was treated with DMSO, acetic acid 
and acetic anhydride. The lone electron pair of the oxygen in DMSO attacks the carbonyl carbon 
from the acetic anhydride, forming a sulfonium intermediate, which rearranges into a carbocation 
intermediate and reacts with the nucleophilic oxygen from the 3’ hydroxyl moiety to form the 
final methylthiomethyl group. 
 
Scheme 2-3 Mechanisms of a modified Pummerer’s rearrangement 
to generate 3’-methylthiomethyl nucleosides. 
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2.2.2 Transformation of Methylthiomethyl Group to tert-Butyldithiomethyl Group 
The 3’-O-methylthiomethyl nucleoside was treated with SO2Cl2 and TEA to generate a 
3’-O-chloromethyl nucleoside intermediate (Scheme 2-4), which can be converted into a 3’-
(tosylthio)methoxy nucleoside by adding potassium thiotosylate. Then, tert-butyl mercaptan was 
added to afford the final product (Scheme 2-5). 
  
Scheme 2-4 Formation of 3’-(tosylthio)methoxy group. The 
generated 3’-O-chloromethyl nucleoside intermediate can be 
converted to a 3’-(tosylthio)methoxy nucleoside with the addition 
of potassium thiotosylate. 
 
 
Scheme 2-5 Formation of tert-butyldithiomethyl group. The 3’-
(tosylthio)methoxy nucleoside can be converted into the more 
stable 3’-O-tert-butyldithiomethyl nucleoside when tert-butyl 




















2.2.3 Addition of O-Dithiomethyl Linker with Sonogashira Coupling  
In the novel nucleotide reversible terminators, DTM serves as both a cleavable linker and 
the 3’ blocking group. The motivation is that in this way both the capping moiety and the 
fluorescent tag will be removed with a single cleavage reaction. A complication of the synthesis, 
however, rises due to the fact that a routine sequential synthesis, with either the linker introduced 
first followed by 3’ modification or the opposite order, will inevitably disrupt the previously 
modified group.  
In order to overcome the aforementioned challenge, we decided to prepare the two parts, 
the DTM linker and the 3’ DTM modified nucleosides separately, and utilize Sonogashira 
coupling to tether them together (Figure 2-5). The Sonogashira reaction, first reported by Heck9 
and Cassar10,  is a palladium-catalyzed C-C cross-coupling reaction between aryl, alkenyl halides 
or triflates and terminal alkynes. 
 
Figure 2-5 Addition of O-dithiomethyl-linker. Sonogashira 
coupling is utilized to create nucleoside analogues containing 





























RCuI, Pd(0), Et3N, r.t. overnight
 52 
2.2.4 Triphosphorylation  
A variety of methods have been developed for the synthesis of nucleoside triphosphates11-
12, involving dichlorophosphates13-16, phosphoramidates17-19, or H-phosphonates20. The Ludwig-
Eckstein method is one of the most popular and reliable procedures for the synthesis of modified 
nucleoside triphosphates. Its advantages include simplicity, high yield, and that all intermediates 
can be conveniently monitored by 31P-NMR.  Here we selected a modified version  of  the “one-
pot, three-step” method developed by Ludwig and Eckstein15, 21 to conduct triphosphorylation on 
the 3’-O-DTM nucleoside.   
 
 
Scheme 2-6 Modified Ludwig-Eckstein synthetic scheme for 
triphosphorylation of 3’-O-DTM nucleoside. 
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A phosphitylating reagent was generated in situ by reacting salicyl phosphorochloridite 
with pyrophosphate, then reacted with the nucleoside to generate a cyclic triphosphate 
intermediate, which later was oxidized by iodine and hydrolyzed in aqueous solution to form a 
nucleoside triphosphate (Scheme 2-6).  
2.2.5 Cleavage of 3’-O-tert-Butyldithiomethyl Group and DTM Linker on Base 
One advantage of employing the new set of 3’-O-tert-butyldithiomethyl-dNTP-SS-Dye 
compounds as fluorescent NRTs for DNA sequencing is the ready cleavage of the disulfide 
group by tris(2-carboxyethyl)phosphine (TCEP) or tris(hydroxypropyl)phosphine (THP). 
Furthermore, the R-O-CH2-SH residue on the cleavage product of the linker will self-decompose 
into a relatively stable OH group, and therefore no longer require a further capping step to 
prevent the active SH group from interfering with the subsequent polymerase reaction. The 
detailed mechanism is illustrated below. 
As denoted in Scheme 2-7, addition of a small amount of TCEP or THP will result in a 
rapid chemical cleavage of disulfide bonds.  Not only is a quick one-step dual cleavage of the S-
S bond achieved, but in addition the R-O-CH2-SH residue will self-collapse to a stable OH 
group, obviating a further capping step and leading to a shorter sequence time and longer read 




Scheme 2-7 Cleavage of 3’-O-DTM group via TCEP and water 
and regeneration of 3’-OH group. 
 
  
Scheme 2-8 Cleavage of DTM linker via TCEP and water and 





1H NMR spectra were recorded on a Bruker DPX-400 (400 MHz) or Bruker DPX-500 (500 
MHz) spectrometer and reported in ppm from a Methanol-d4,Chloroform-d or DMSO-d6 internal 
standard (3.31 7.26 and 2.50 ppm respectively).  Proton decoupled 13C NMR spectra were recorded 
on a Bruker DPX-300 (300 MHz) spectrometer or Bruker DPX-500 (500 MHz) spectrometer and 
reported in ppm from a Methanol-d4,Chloroform-d or DMSO-d6 internal standard (49.86, 77.36 
and 39.51 ppm respectively). 19F NMR spectra were recorded on a Bruker DPX-400 (400 MHz) 
spectrometer. Data were reported as follows: (s = singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet, dd = doublet of doublets, ddd = doublet of doublets of doublets; coupling constant(s) in 
Hz; integration; assignment). High resolution mass spectra (HRMS) were obtained on a Waters 
XEVO G2XS QToF mass spectrometer equipped with a UPC2 SFC inlet and a LockSpray source 
with one of three probes: electrospray ionization (ESI) probe, atmospheric pressure chemical 
ionization (APCI) probe, or atmospheric pressure solids analysis probe (ASAP). Mass 
measurement of DNA and some of the nucleoside triphosphate analogues was performed on a 
Voyager DE MALDI-TOF mass spectrometer (Applied Biosystems). Mass measurements of 3’-
O-tert-butyldithiomethyl-dNTP-SS-Dye analogues were performed on a Bruker ultrafleXtreme 
MALDI TOF/TOF with a frequency-tripled Nd:YAG laser (355 nm) or a high-resolution mass 
spectrometer as previously mentioned. HPLC was used to purify the nucleosides triphosphates (C-
18 reverse phase column, elution gradient: B 0% in A to 50% in 40 min, A: HFIP-TEA buffer, B: 
Methanol). N6-benzoyl-5’-O-TBDMS-2’-deoxyadenosine was purchased from TCI. N2-iso-
butyryl -5’-O-TBDMS -2’- deoxyguanosine was purchased from VWR. 5 or 7 Iodo nucleosides 
were purchased from Berry & Associates and ChemGene. Dye NHS esters were purchased from 
Molecular Probes or GE Healthcare. All other chemicals were purchased from Sigma-Aldrich.  
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2.3.1 Synthesis of 3’-O-tert-Butyldithiomethyl-dTTP 
 
 
Scheme 2-9 Synthesis of 3’-O-tert-butyldithiomethyl-dTTP. 
3’-O-Methylthiomethyl-5’-O-tert-Butyldimethylsilyl Thymidine (Compound 2) 
To a solution of 5’-O-tert-butyldimethylsilyl thymidine (Compound 1, 1.07 g, 3 mmol) in 
DMSO (10 mL) with stirring at room temperature was added acetic acid (2.6 mL, 45 mmol) and 
acetic anhydride (8.6mL, 91 mmol). The reaction mixture was stirred for 18 hours and TLC 
analysis (ethyl acetate/hexane: 3:7) showed the complete consumption of Compound 1. The 
reaction mixture was then poured into a saturated solution of sodium bicarbonate (100 mL) with 
vigorous stirring and extracted with ethyl acetate (3 × 30 mL). The organic layer was dried over 
Na2SO4 and concentrated to afford the crude product. The crude product was purified by column 
chromatography on silica gel eluted with ethyl acetate/hexane: 3:7 to give Compound 2 (0.97 g, 
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78 %) as a white solid. 1H NMR (500 MHz, DMSO-d6) δ 11.35 (s, 1H), 7.48 (d, J = 1.4 Hz, 1H), 
6.13 (dd, J = 8.6, 5.7 Hz, 1H), 4.71 (s, 2H), 4.40 (dt, J = 6.0, 2.1 Hz, 1H), 3.98 (td, J = 4.1, 2.0 Hz, 
1H), 3.82 – 3.71 (m, 2H), 2.26 (ddd, J = 13.6, 5.7, 2.0 Hz, 1H), 2.18 – 2.11 (m, 1H), 2.10 (s, 3H), 
1.79 (d, J = 1.2 Hz, 3H), 0.89 (s, 9H), 0.09 (d, J = 1.8 Hz, 6H). 13C NMR (500 MHz, DMSO-d6) δ 
164.05, 150.80, 135.77, 110.04, 84.49, 84.42, 76.43, 73.01, 63.60, 36.51, 26.20, 18.40, 13.70, 
12.67, -5.03, -5.06. HRMS (ESI+) calc’d for C18H33N2O5SSi [(M+H)+]: 417.1880, found: 
417.1876. 
3’-O-tert-Butyldithiomethyl-5’-O-tert-Butyldimethylsilyl Thymidine (Compound 3) 
To a solution of Compound 2 (420 mg, 1.01 mmol) in anhydrous dichloromethane (20 
mL) was added triethylamine (0.18 mL, 1.29 mmol) and molecular sieves (3 Å, 2g). The mixture 
was cooled in an ice bath with stirring for 30 min. A solution of freshly distilled sulfuryl chloride 
(0.1 mL, 1.25 mmol) in anhydrous dichloromethane (3 mL) was then added dropwise under 
argon. The ice bath was removed and the reaction mixture was stirred at room temperature for 30 
minutes. Potassium 4-toluenethiosulfonate (375 mg, 1.66 mmol) dissolved in anhydrous DMF (2 
mL) was added to the mixture. The stirring was continued at room temperature for another 1 
hour, followed by addition of tert-butyl mercaptan (1 mL) and stirring for another 30 minutes. 
The mixture was then filtered through a Celite pad, and the filtrate was concentrated to afford the 
crude product, Compound 3. 
3’-O-tert-Butyldithiomethyl Thymidine (Compound 4)  
Without isolation, Compound 3 was dissolved in dry THF (10 mL). To the solution was 
added a THF solution of TBAF (1.0M, 1.04 mL, 1.04 mmol) with stirring. The reaction mixture 
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was stirred at room temperature for 4 hours and TLC analysis (dichloromethane/methanol, 95:5) 
showed the complete consumption of Compound 3. The reaction mixture was concentrated in 
vacuo, added into a vigorously stirred saturated solution of NaHCO3 (50 mL) and extracted with 
dichloromethane (3 × 20 mL ). The organic layer was dried over Na2SO4 and concentrated to afford 
the crude product. The crude product was purified by column chromatography on silica gel eluted 
with dichloromethane/methanol (95:5) to give Compound 4 (132 mg, 33 % from Compound 2) as 
a white solid.  1H NMR (500 MHz, DMSO-d6) δ 11.30 (s, 1H), 7.70 (d, J = 1.5 Hz, 1H), 6.13 (dd, 
J = 8.5, 5.8 Hz, 1H), 5.15 (t, J = 5.2 Hz, 1H), 4.88 (d, J = 1.8 Hz, 2H), 4.41 (dt, J = 6.1, 2.2 Hz, 
1H), 3.97 (td, J = 3.8, 2.1 Hz, 1H), 3.60 (tdt, J = 11.8, 8.1, 4.2 Hz, 2H), 2.26 (ddd, J = 13.7, 5.9, 
2.2 Hz, 1H), 2.18 (ddd, J = 13.9, 8.5, 5.9 Hz, 1H), 1.78 (d, J = 1.1 Hz, 3H), 1.30 (s, 9H). 13C NMR 
(500 MHz, DMSO-d6) δ 164.13, 150.89, 136.35, 110.02, 84.89, 84.26, 80.21, 78.43, 61.84, 47.52, 
36.66, 30.09, 12.73. HRMS (ESI+) calc’d for C15H25N2O5S2 [(M+H)+]: 377.1205, found: 377.1204. 
3’-O-tert-Butyldithiomethyl-dTTP (Compound 5)  
Compound 4 (50 mg, 0.13 mmol), tributylammonium pyrophosphate (TBAP) (197 mg, 
0.36 mmol), and SalPCl (44 mg, 0.22 mmol) were dried overnight separately over phosphorus 
pentoxide in vacuum desiccators at room temperature.  TBAP was dissolved in anhydrous DMF 
(1 mL) and tributylamine (1 mL) was added at room temperature under argon. The solution was 
added into a solution of SalPCl in anhydrous DMF (2 mL) under argon and the mixture was stirred 
at room temperature for 1 hour. A solution of 3’-O-tert-butyldithiomethyl-thymidine in DMF 
(1mL) was then added, and the mixture was stirred at room temperature for 1 hour. Subsequently, 
iodine solution (0.02 M iodine/pyridine/water) was added carefully until the mixture turned a 
permanent brown color. The solution was further stirred at room temperature for 10 minutes, 
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followed by addition of water (30mL) and another 2 hours of stirring. The reaction mixture was 
then washed with ethyl acetate (2 × 30mL). The aqueous layer was concentrated in vacuo and 
diluted with 5ml of water, followed by purification by anion exchange chromatography on DEAE-
Sephadex A-25 at 4°C using gradient elution of triethylammonium bicarbonate (TEAB) buffer 
(pH 8.0; 0.1–1.0 M). The crude product was further purified by reverse-phase HPLC to afford 
Compound 5. HRMS (ESI-) calc’d for C15H26N2O14P3S2 [(M-H)-]: 615.0038, found: 615.0034. 
2.3.2 Synthesis of 3’-O-tert-Butyldithiomethyl-dCTP  
 
Scheme 2-10  Synthesis of 3’-O-tert-butyldithiomethyl-dCTP 
N4-Benzoyl-3’-O-Methylthiomethyl-5’-O-TBDMS-2’-Deoxycytidine (Compound 7) 
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To a solution of N4-Benzoyl-5’-O-TBDMS-2’-deoxycytidine (Compound 6, 1.5g, 
3.4mmol) in DMSO (6.5 mL) with stirring was added acetic acid (2.91 mL, 50 mmol) and acetic 
anhydride (9.29 mL, 98mmol). The reaction mixture was stirred at room temperature for 2 days, 
then poured into a saturated solution of sodium bicarbonate (100 mL) with stirring and extracted 
with ethyl acetate (3 × 50mL). The obtained crude product was dried over Na2SO4, concentrated 
under reduced pressure, and purified by column chromatography (ethyl acetate/hexane, 8:2) to 
give pure product, Compound 7 (1.26 g, 74%), as a white solid. 1H NMR (400 MHz, Chloroform-
d) δ 8.43 (d, J = 7.4 Hz, 1H), 7.92 (d, J = 7.6 Hz, 2H), 7.69 – 7.50 (m, 4H), 6.31 (t, J = 6.1 Hz, 
1H), 4.75 – 4.59 (m, 2H), 4.51 (dt, J = 6.2, 3.9 Hz, 1H), 4.20 (dt, J = 3.7, 2.6 Hz, 1H), 4.01 (dd, J 
= 11.4, 2.9 Hz, 1H), 3.86 (dd, J = 11.4, 2.4 Hz, 1H), 2.72 (ddd, J = 13.8, 6.2, 4.1 Hz, 1H), 2.18 (s, 
4H), 0.97 (s, 9H), 0.17 (d, J = 3.9 Hz, 6H). HRMS (ESI+) calc’d for C24H36N3O5SSi [(M+H)+]: 
506.2145, found: 506.2146. 
N4-Benzoyl-3’-O-tert-Butyldithiomethyl-5’-O-TBDMS-2’-Deoxycytidine (Compound 8) 
Compound 7 (1.01g, 2 mmol) was dissolved in anhydrous dichloromethane (8 mL), 
followed by addition of triethylamine (0.28 mL, 2 mmol) and molecular sieves (3 Å, 1 g). The 
mixture was cooled in an ice bath after stirring at room temperature for 30 minutes and then a 
solution of sulfuryl chloride (0.16 mL, 2 mmol) in anhydrous dichloromethane (8 mL) was added 
dropwise. The ice bath was removed and the reaction mixture was stirred for 30 minutes. 
Potassium p-toluenethiosulfonate (678 mg, 3 mmol) in anhydrous DMF (1 mL) was added into 
the mixture and the stirring was continued at room temperature for another 1 hour, followed by 
addition of tert-butyl mercaptan (0.676 mL). The reaction mixture was stirred at room temperature 
for an additional 30 minutes and quickly filtered. The solvent was removed under reduced pressure 
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and the residue was dissolved in ethyl acetate and washed with brine (3 × 50mL). The combined 
organic layers were dried over Na2SO4 and filtered. The filtrate was concentrated to dryness under 
reduced pressure and the residue was purified by silica gel column chromatography with ethyl 
acetate/hexane: (3:7→5:5), yielding 959 mg (83%) Compound 8 as a white solid. 1H NMR (400 
MHz, Methanol-d4) δ 8.50 (d, J = 7.6 Hz, 1H), 8.05 – 7.97 (m, 2H), 7.71 – 7.59 (m, 2H), 7.57 (dd, 
J = 8.3, 6.9 Hz, 2H), 6.22 (t, J = 6.3 Hz, 1H), 5.00 – 4.87 (m, 2H), 4.59 (dt, J = 6.3, 3.3 Hz, 1H), 
4.28 (q, J = 2.9 Hz, 1H), 4.03 (dd, J = 11.5, 3.0 Hz, 1H), 3.93 (dd, J = 11.5, 2.7 Hz, 1H), 2.73 (ddd, 
J = 13.9, 6.1, 3.4 Hz, 1H), 2.26 (dt, J = 13.0, 6.3 Hz, 1H), 1.36 (s, 9H), 0.98 (s, 9H), 0.19 (d, J = 
1.7 Hz, 6H). HRMS (ESI+) calc’d for: C27H42N3O5S2Si [(M+H)+]:580.2335, found: 580.2329. 
N4-Benzoyl-3’-O-tert-Butyldithiomethyl-2’-Deoxycytidine (Compound 9) 
To a stirred solution of Compound 8 (958 mg, 1.66 mmol) in tetrahydrofuran (24 mL), 
TBAF (1.0M, 2.48 mL, 2.48 mmol) was added in small portions. The mixture was stirred at room 
temperature for 3 hours, then poured into a saturated sodium bicarbonate solution (50 mL) and 
extracted with ethyl acetate (3 × 50mL).  The combined organic layers were dried over Na2SO4 
and filtered. The filtrate was concentrated to dryness under reduced pressure and the residue of the 
desired compound was purified by silica gel column chromatography (ethyl acetate/hexane, 5:5), 
to give 435 mg (47%) Compound 9 as a white solid. 1H NMR (400 MHz, Methanol-d4) δ 8.52 (d, 
J = 7.5 Hz, 1H), 8.04 – 7.96 (m, 2H), 7.71 – 7.60 (m, 2H), 7.61 – 7.51 (m, 2H), 6.28 – 6.19 (m, 
1H), 4.95 – 4.86 (m, 2H),  4.54 (dt, J = 6.0, 3.0 Hz, 1H), 4.23 (q, J = 3.4 Hz, 1H), 3.92 – 3.76 (m, 
2H), 2.70 (ddd, J = 13.9, 6.0, 2.9 Hz, 1H), 2.25 (ddd, J = 13.6, 7.2, 6.2 Hz, 1H), 1.37 (s, 9H). 
HRMS (ESI+) calc’d for C21H28N3O5S2 [(M+H) +]: 466.1470, found: 466.1478. 
3’-O-tert-Butyldithiomethyl-dCTP (Compound 10) 
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Compound 9 (50 mg, 0.11 mmol), tributylammonium pyrophosphate (180 mg, 0.33 
mmol) and SalPCl (44 mg, 0.22 mmol) were dried separately over phosphorus pentoxide in 
vacuum desiccators overnight under high vacuum at ambient temperature. To a solution of 
SalPCl in anhydrous DMF (2 mL) was added under argon a solution of TBAP and tributylamine 
(1 mL) dissolved in anhydrous DMF (1 mL). The mixture was stirred at room temperature for 1 
hour, then added to the solution of Compound 9 in DMF (1mL) and was stirred for another 1 
hour at room temperature. Subsequently, iodine solution (0.02 M iodine/pyridine/water) was 
added until the mixture turned a permanent brown color. After 10 min, water (30mL) was added, 
and the reaction mixture was stirred at room temperature for an additional 2 hours. The resulting 
solution was washed with ethyl acetate (2 × 30mL). The aqueous layer was concentrated in 
vacuo to approximately 20 mL, then concentrated NH4OH (20 ml) was added and the solution 
was stirred overnight at room temperature. The mixture was concentrated under vacuum and the 
residue was diluted with 5 ml of water. The crude mixture was then purified by anion exchange 
chromatography on DEAE-Sephadex A-25 at 4°C using a gradient of TEAB (pH 8.0; 0.1–1.0 
M). The crude product was further purified by reverse-phase HPLC to afford Compound 10. 
HRMS (ESI-) calc’d for C14H25N3O13P3S2 [(M-H)-]: 600.0042, found: 600.0033. 
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2.3.3 Synthesis of 3’-O-tert-Butyldithiomethyl-dATP 
 
Scheme 2-11 Synthesis of 3’-O-tert-butyldithiomethyl-dATP. 
N6-Benzoyl-3’-O-Methylthiomethyl-5’-O-TBDMS -2’-Deoxyadenosine (Compound 12) 
To a solution of N6-benzoyl-5’-O-TBDMS -2’-deoxyadenosine, Compound 11 (1.4 g, 3 
mmol) in DMSO (10 mL) was added with stirring acetic acid (3 mL, 52 mmol) and acetic 
anhydride (9 mL, 95 mmol). The reaction mixture was stirred at room temperature overnight, then 
poured into a saturated solution of sodium bicarbonate with stirring and extracted with ethyl 
acetate (3 x 30mL). The obtained crude product was dried over Na2SO4, solvents removed under 
reduced pressure, and purified by column chromatography (dichloromethane/methanol, 30:1) to 
give pure product, Compound 12 (1.39 g, 87%), as a white solid. 1H NMR (400 MHz, Methanol-
d4) δ 8.74 (s, 1H), 8.62 (s, 1H), 8.15 – 8.07 (m, 2H), 7.73 – 7.63 (m, 1H), 7.63 – 7.55 (m, 2H), 
6.55 (t, J = 6.6 Hz, 1H), 4.79 (dd, J = 6.4, 3.0 Hz, 3H), 4.22 (dt, J = 4.8, 3.7 Hz, 1H), 3.96 (dd, J 
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= 11.1, 4.8 Hz, 1H), 3.87 (dd, J = 11.1, 3.8 Hz, 1H), 3.00 – 2.87 (m, 1H), 2.69 (ddd, J = 13.7, 6.2, 
3.4 Hz, 1H), 2.20 (s, 3H), 0.93 (s, 9H), 0.12 (d, J = 1.4 Hz, 6H). HRMS (ESI+) calc’d for 
C25H36N5O4SSi [(M+H)+]: 530.2257, found: 530.2254. 
N6-Benzoyl-3’-O-tert-Butyldithiomethyl-5’-O-TBDMS-2’-Deoxyadenosine (Compound 13) 
Compound 12 (0.529g, 1 mmol) was dissolved in anhydrous dichloromethane (20 mL), 
followed by addition of triethylamine (0.17 mL, 1.2 mmol) and molecular sieves (3 Å, 2 g). The 
mixture was cooled in an ice bath after stirring at room temperature for 30 minutes and then a 
solution of freshly distilled sulfuryl chloride (0.095 mL, 1.2 mmol) in anhydrous dichloromethane 
(3 mL) was added dropwise. The ice bath was removed and the reaction mixture was stirred at 
room temperature for another 30 minutes. Then potassium p-toluenethiosulfonate (341 mg, 1.5 
mmol) dissolved in anhydrous DMF (2 mL) was added to the mixture, and the stirring was 
continued at room temperature for another 1 hour, followed by addition of tert-butyl mercaptan (1 
mL). The reaction mixture was stirred at room temperature for 30 minutes and quickly filtered 
through a Celite pad. The filtrate was concentrated to afford the crude product, Compound 13 
N6-Benzoyl-3’-O-tert-Butyldithiomethyl-2’-Deoxyadenosine (Compound 14) 
The crude Compound 13 was dissolved in dry THF (10 mL). To the solution with stirring 
at room temperature was added a THF solution of TBAF (1.0M, 1.04 mL, 1.04 mmol). The 
reaction mixture was stirred at room temperature for 4 hours and TLC analysis 
(dichloromethane/methanol, 95:5) showed the complete consumption of Compound 13. The 
reaction mixture was concentrated in vacuo, added into stirred saturated NaHCO3 solution (50 mL) 
with vigorous stirring and extracted with dichloromethane (3 × 20 mL). The organic layer was 
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dried over Na2SO4 and concentrated. The afforded crude product was purified by column 
chromatography on silica gel eluted with dichloromethane/methanol (95:5) to give Compound 14 
(128 mg, 26 % from Compound 12) as a white solid. 1H NMR (500 MHz, Chloroform-d) δ 9.40 
(s, 1H), 8.73 (s, 1H), 8.10 (s, 1H), 8.02 (dt, J = 7.2, 1.3 Hz, 2H), 7.63 – 7.54 (m, 1H), 7.54 – 7.46 
(m, 2H), 6.33 (dd, J = 9.3, 5.5 Hz, 1H), 5.87 – 5.80 (m, 1H), 4.90 – 4.80 (m, 2H), 4.76 – 4.71 (m, 
1H), 4.34 (q, J = 1.8 Hz, 1H), 3.99 (dt, J = 12.8, 1.9 Hz, 1H), 3.81 (ddd, J = 12.8, 10.8, 2.1 Hz, 
1H), 3.01 (ddd, J = 13.6, 9.4, 5.5 Hz, 1H), 2.52 (ddd, J = 13.6, 5.6, 1.2 Hz, 1H), 1.35 (s, 9H). 
HRMS (ESI+) calc’d for: C22H28N5O4S2 [(M+H) +]:490.1583, found: 490.1581. 
3’-O-tert-Butyldithiomethyl-dATP (Compound 15) 
Compound 14 (50 mg, 0.10 mmol), tributylammonium pyrophosphate (TBAP) (180 mg, 
0.33 mmol), and SalPCl (44 mg, 0.22 mmol) were dried separately over phosphorus pentoxide in 
vacuum desiccators at room temperature overnight. To a solution of SalPCl in anhydrous DMF (2 
mL), TBAP and tributylamine (1 mL) dissolved in anhydrous DMF (1 mL) were added under 
argon at room temperature. The mixture was stirred for 1 hour at room temperature, then added to 
the solution of Compound 14 in DMF (1mL) and was stirred for another 1 hour at room 
temperature. Subsequently, iodine solution (0.02 M iodine/pyridine/water) was added until the 
color of the mixture turned a permanent brown.  The solution was further stirred for 10 minutes, 
followed by addition of water (30mL) and another 2 hours of stirring. The reaction mixture was 
then washed with ethyl acetate (2 × 30mL). The aqueous layer was concentrated in vacuo to 
approximately 20 mL, then concentrated NH4OH (20 ml) was added and the solution was stirred 
overnight at room temperature. The aqueous layer was concentrated in vacuo and diluted with 5ml 
of water, followed by purification by anion exchange chromatography on DEAE-Sephadex A-25 
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at 4°C using a gradient of TEAB (pH 8.0; 0.1–1.0 M). The crude product was further purified by 
reverse-phase HPLC to afford Compound 15. HRMS (ESI-) calc’d for: C15H25N5O12P3S2 [(M-
H)-]:624.0154, found: 624.0151. 
2.3.4 Synthesis of 3’-O-tert-Butyldithiomethyl-dGTP 
 
Scheme 2-12 Synthesis of 3’-O-tert-butyldithiomethyl-dGTP. 
N2-iso-Butyryl-3’-O-Methylthiomethyl-5’-O-TBDMS -2’- Deoxyguanosine (Compound 17) 
To a solution of N2-iso-butyryl -5’-O-TBDMS -2’- deoxyguanosine (Compound 16, 1.31 
g, 2.9 mmol) in DMSO (10 mL) with stirring was added acetic acid (2.6 mL, 45 mmol) and 
acetic anhydride (8.6 mL, 91 mmol). The reaction mixture was stirred at room temperature 
overnight, then poured into a saturated solution of sodium bicarbonate with stirring and extracted 
with ethyl acetate (3 x 30mL). The obtained crude product was dried over Na2SO4, solvents 
removed under reduced pressure, and purified by column chromatography 
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(dichloromethane/methanol, 20:1) to give pure product, Compound 17 (1.15 g, 80%), as a white 
solid. 1H NMR (400 MHz, DMSO-d6) δ 12.06 (s, 1H), 11.64 (s, 1H), 8.19 (s, 1H), 6.19 (dd, J = 
8.1, 5.7 Hz, 1H), 4.75 (s, 2H), 4.54 (dt, J = 5.4, 2.5 Hz, 1H), 4.03 (ddd, J = 8.0, 4.1, 1.8 Hz, 1H), 
3.81 – 3.67 (m, 2H), 2.85 – 2.66 (m, 2H), 2.12 (s, 3H), 1.15 – 1.12 (m, 6H), 0.88 (s, 9H), 0.06 (s, 
6H). HRMS (ESI+) calc’d for C21H36N6O4SSi [(M+H)-]: 497.2366, found: 497.2369. 
N2-iso-Butyryl-3’-O-tert-Butyldithiomethyl-5’-O-TBDMS-2’-Deoxyguanosine (Compound 
18) 
Compound 17 (0.51g, 1 mmol) was dissolved in anhydrous dichloromethane (20 mL), 
followed by addition of triethylamine (0.17 mL, 1.2 mmol) and molecular sieves (3 Å, 1 g). The 
mixture was cooled in an ice bath after stirring at room temperature for 30 minutes and then a 
solution of sulfuryl chloride (0.095 mL, 1.2 mmol) in anhydrous dichloromethane (8 mL) was 
added dropwise. The ice bath was removed and the reaction mixture was stirred for another 30 
minutes. Then potassium p-toluenethiosulfonate (341 mg, 1.5 mmol) in anhydrous DMF (2 mL) 
was added to the mixture. Stirring was continued at room temperature for another 1 hour, followed 
by addition of tert-butyl mercaptan (1 mL). The reaction mixture was stirred at room temperature 
for 30 minutes and quickly filtered. The solvent was removed under reduced pressure and the 
residue was dissolved in ethyl acetate and washed with brine (3 × 50mL). The combined organic 
layers were dried over Na2SO4 and filtered. The reaction mixture was stirred at room temperature 
for 30 minutes and quickly filtered through a Celite pad, and the filtrate was concentrated to afford 
the crude product Compound 18. 
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 N2-iso-Butyryl-3’-O- tert-Butyldithiomethyl -2’-Deoxyguanosine (Compound 19) 
The crude Compound 18 was dissolved in dry THF (10 mL). To the solution with stirring 
at room temperature was added a THF solution of TBAF (1.0M, 1.04 mL, 1.04 mmol) in small 
portions. The mixture was stirred at room temperature for 4 hours, then poured into a saturated 
sodium bicarbonate solution (50 mL) and extracted with dichloromethane (3 x 20mL).  The 
combined organic layers were dried over Na2SO4 and filtered. The filtrate was concentrated to 
dryness under reduced pressure and the residue of the desired compound was purified by silica gel 
column chromatography (dichloromethane/methanol, 95:5), to give compound 19 (155mg, 33% 
from Compound 17) as a white solid. 1H NMR (400 MHz, Chloroform-d) δ 9.44 (s, 1H), 7.97 (s, 
1H), 6.17 (dd, J = 8.4, 5.9 Hz, 1H), 5.32 (s, 1H), 4.92 – 4.80 (m, 2H), 4.68 (dt, J = 6.0, 2.1 Hz, 
1H), 4.26 (q, J = 2.6 Hz, 1H), 3.98 (dd, J = 12.2, 2.8 Hz, 1H), 3.85 – 3.76 (m, 1H), 2.93 – 2.71 (m, 
2H), 2.49 (ddd, J = 13.7, 6.0, 2.1 Hz, 1H), 1.35 (s, 9H), 1.27 (dd, J = 7.7, 6.9 Hz, 6H).  
3’-O-tert-Butyldithiomethyl-dGTP (Compound 20) 
Compound 19 (50 mg, 0.11 mmol), tributylammonium pyrophosphate (TBAP) (180 mg, 
0.33 mmol), and SalPCl (44 mg, 0.22 mmol) were dried separately over phosphorus pentoxide in 
vacuum desiccators at room temperature overnight.  To a solution of SalPCl in anhydrous DMF 
(2 mL), TBAP and tributylamine (1 mL) dissolved in anhydrous DMF (1 mL) were added under 
argon at room temperature. The mixture was stirred at room temperature for 1 hour, then added to 
the solution of Compound 19 in DMF (1mL) and stirred for 1 hour at room temperature. 
Subsequently, iodine solution (0.02 M iodine/pyridine/water) was added until the color of the 
mixture turned a permanent brown. The solution was further stirred for 10 minutes, followed by 
addition of water (30mL) and another 2 hours of stirring. The reaction mixture was then washed 
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with ethyl acetate (2 × 30mL). The aqueous layer was concentrated in vacuo to 20mL. Then 
concentrated NH4OH (20 ml) was added and stirred overnight at room temperature. The solution 
was concentrated in vacuo and the residue was diluted with 5ml of water, followed by purification 
by anion exchange chromatography on DEAE-Sephadex A-25 at 4°C using a gradient of TEAB 
(pH 8.0; 0.1–1.0 M). The crude product was further purified by reverse-phase HPLC to afford 
Compound 20. HRMS (ESI-) calc’d for C15H26N5O13P3S2 [(M-H)-]: 640.0103, found: 640.0099. 
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2.3.5 Synthesis of DTM Linker  
 
Scheme 2-13 Synthesis of DTM linker 
Trimethyl (3-(Methylthiomethoxy) Prop-1-yn-1-yl) Silane (Compound 22) 
To a solution of 3-(trimethylsilyl) propargyl alcohol (1.28 g, 10 mmol) in DMSO (10 
mL) with stirring was added acetic acid (2.6 mL, 45 mmol) and acetic anhydride (8.6 mL, 91 
mmol). The reaction mixture was stirred at room temperature for 10 hours and TLC analysis 
(ethyl acetate/hexane, 1:10) showed the complete consumption of Compound 21. The reaction 
mixture was poured into a solution of saturated sodium bicarbonate with vigorous stirring and 
extracted with ethyl acetate (3 × 30 mL). The combined organic layers were dried over Na2SO4 
and concentrated to afford the crude product. The crude product was purified by column 
chromatography on silica gel eluted with a gradient of hexanes → ethyl acetate/hexane (1:10) to 
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give Compound 22 (0.97 g, 67 %). 1H NMR (400 MHz, Chloroform-d) δ 4.76 (s, 2H), 4.30 (s, 
2H), 2.18 (s, 3H), 0.21 (s, 9H). 13C NMR (75 MHz, Chloroform-d) δ 101.11, 92.11, 74.06, 55.50, 
14.44, 0.19. 
2, 2, 2-Trifluoro-N-(2-Mercapto-2-Methylpropyl) Acetamide (Compound 24) 
To a stirred solution of Compound 23 (1 g, 7 mmol) mixed with pyridine (2mL) in dry 
benzene (15 mL) was slowly added trifluoroacetic anhydride (1.30 mL, 9.2 mmol) at 0 oC.  The 
mixture was stirred at room temperature overnight, then carefully added into 0.5 M Na2CO3/H2O 
and extracted with ethyl acetate (3 × 30 mL). The organic layer was dried over Na2SO4 and 
concentrated to afford the crude product. The crude product was purified by column 
chromatography on silica gel eluted with ethyl acetate/hexanes (3:7) to give Compound 24 (1 g, 
70 %). 1H NMR (400 MHz, Chloroform-d) δ 6.83 (s, 1H), 3.44 (dd, J = 6.3, 0.7 Hz, 2H), 1.69 (s, 
1H), 1.41 (d, J = 0.9 Hz, 6H). 13C NMR (75 MHz, Chloroform-d) δ 158.20, 157.72, 118.21, 
114.40, 52.73, 45.00, 30.00.19F NMR (376 MHz, Chloroform-d) δ -74.93. 
S-(((3-(Trimethylsilyl) Prop-2-yn-1-yl) oxy) methyl) 4-Methylbenzenesulfonothioate  
(Compound 25) 
 
Compound 22 (1000 mg, 5.32 mmol) was dissolved in anhydrous dichloromethane (10 
mL), followed by addition of triethylamine (0.3 mL, 2.16 mmol), cyclohexene (3.4 mL) and 
molecular sieves (3 Å, 2 g). The mixture was cooled in an ice bath after stirring at room 
temperature for 30 minutes and then a solution of freshly distilled sulfuryl chloride (0.47 mL, 
5.86 mmol) in anhydrous dichloromethane (3 mL) was added dropwise. The ice bath was 
removed and the reaction mixture was stirred for another 1 hour. Then potassium p-
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toluenethiosulfonate (1440 mg, 6.36 mmol) in anhydrous DMF (5 mL) was added to the mixture. 
Stirring was continued at room temperature for another 1 hour. The solvent was removed under 
reduced pressure and the residue was purified by silica gel column chromatography with ethyl 
acetate/hexane (1:10), yielding Compound 25 (1290 mg, 74%). 1H NMR (400 MHz, 
Chloroform-d) δ 7.90 – 7.81 (m, 2H), 7.42 – 7.30 (m, 2H), 5.41 (s, 2H), 4.03 (s, 2H), 2.46 (s, 
3H), 0.19 (s, 9H).  
2,2,2-Trifluoro-N-(2-Methyl-2-(((Prop-2-yn-1-yloxy) Methyl) Disulfanyl) Propyl) Acetamide 
(Compound 27)    
To a stirred solution of Compound 24 (0.87g, 4.33 mmol) dissolved in 20 mL dry 
dichloromethane was added triethylamine (0.3 mL, 2.16 mmol) and compound 25 (1.29g, 3.93 
mmol).  The mixture was stirred at room temperature for 30 minutes, followed by the addition of 
tetrabutylammonium fluoride (TBAF) THF solution (1.0M, 5.89 mL, 5.89 mmol). The reaction 
mixture was stirred at room temperature for 10 minutes, and then concentrated under reduced 
vacuum. The residue was purified by silica gel column chromatography with ethyl acetate/hexane 
(1:10), yielding Compound 27 (0.83g, 70%).1H NMR (400 MHz, Chloroform-d) δ 7.19 (s, 1H), 
4.89 (s, 2H), 4.32 (d, J = 2.4 Hz, 2H), 3.47 (dd, J = 6.4, 0.7 Hz, 2H), 2.51 (t, J = 2.4 Hz, 1H), 1.33 
(s, 6H).13C NMR (75 MHz, Chloroform-d) δ 158.19, 118.28, 114.46, 79.79, 77.90, 76.31, 56.61, 
51.00, 47.27, 25.96. 19F NMR (376 MHz, DMSO-d6) δ -73.09 (d, J = 7.8 Hz). 
 73 
2.3.6 Synthesis of 3’-O-tert-Butyldithiomethyl-dUTP-5-SS-R6G 
 
 
Scheme 2-14 Synthesis of 3’-O-tert-butyldithiomethyl-dUTP-5-SS-R6G 
 
5-Iodo-5’-O-tert-Butyldimethylsilyl-Deoxyuridine (Compound 29) 
To a mixture of 5-Iodo-5’-O-tert-butyldimethylsilyl-deoxyuridine (Compound 28, 2g, 
5.6mmol) and imidazole (420 mg, 6.2 mmol) in dry DMF (30 mL) was added tert-
butyldimethylsilyl chloride (936 mg, 6.2 mmol). The mixture was stirred at room temperature 
overnight, then poured into ice water (200mL) with stirring and extracted with ethyl acetate (3 × 
50 mL). The obtained crude product was dried over Na2SO4, solvents removed under reduced 
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pressure, and purified by column chromatography (dichloromethane/methanol, 20:1) to give pure 
Compound 29 (2.11 g, 80%) as a white solid. 1H NMR (400 MHz, DMSO-d6) δ 11.74 (s, 1H), 
8.01 (s, 1H), 6.10 (dd, J = 7.9, 5.9 Hz, 1H), 5.31 (d, J = 4.1 Hz, 1H), 4.18 (dq, J = 6.5, 2.6 Hz, 1H), 
3.87 (q, J = 2.9 Hz, 1H), 3.81 (dd, J = 11.5, 2.8 Hz, 1H), 3.73 (dd, J = 11.5, 3.5 Hz, 1H), 2.14 (ddd, 
J = 13.2, 5.9, 2.6 Hz, 1H), 2.05 (ddd, J = 13.4, 8.0, 5.7 Hz, 1H), 0.91 (s, 9H), 0.12 (d, J = 4.0 Hz, 
6H). HRMS (ESI+) calc’d for: C15H25IN2O5SiNa [(M+Na) +]:491.0475, found: 491.0470. 
5-Iodo-5’-O-tert-Butyldimethylsilyl-3’-O-Methylthiomethyl-Deoxyuridine (Compound 30) 
To a solution of Compound 29 (1g, 2.1 mmol) in DMSO (10 mL) with stirring was added 
acetic acid (3 mL, 52 mmol) and acetic anhydride (8.1 mL, 85mmol). The reaction mixture was 
stirred at room temperature for 2 days, then poured into a solution of saturated sodium bicarbonate 
with stirring and extracted with ethyl acetate (3 × 50 mL). The obtained organic layers were dried 
over Na2SO4, concentrated under reduced pressure, and purified by column chromatography 
(dichloromethane/methanol, 30:1) to give pure product, Compound 30 (789 mg, 69%), as a white 
solid.1H NMR (400 MHz, Chloroform-d) δ 9.56 (s, 1H), 8.09 (s, 1H), 6.23 (dd, J = 8.4, 5.5 Hz, 
1H), 4.72 – 4.58 (m, 2H), 4.47 (dt, J = 6.0, 1.8 Hz, 1H), 4.19 – 4.07 (m, 1H), 3.91 (dd, J = 11.4, 
2.7 Hz, 1H), 3.81 (dd, J = 11.4, 2.5 Hz, 1H), 2.50 (ddd, J = 13.6, 5.6, 1.7 Hz, 1H), 2.13 (s, 3H), 
2.07 – 1.94 (m, 1H), 0.95 (s, 9H), 0.17 (d, J = 5.2 Hz, 6H). 13C NMR (75 MHz, Chloroform-d) δ 
160.59, 150.51, 144.64, 86.36, 85.97, 77.01, 73.90, 69.04, 63.92, 38.91, 26.56, 18.87, 14.29, -4.71, 





Compound 30 (754 mg, 1.42 mmol) was dissolved in anhydrous dichloromethane (20 mL), 
followed by addition of triethylamine (0.3 mL, 2.16 mmol) and molecular sieves (3 Å, 2 g). The 
mixture was cooled in an ice bath after stirring at room temperature for 30 minutes and a solution 
of sulfuryl chloride (0.12 mL, 1.50 mmol) in anhydrous dichloromethane (3 mL) was added 
dropwise. The ice bath was removed and the reaction mixture was stirred for another 30 minutes. 
Then potassium p-toluenethiosulfonate (610 mg, 2.69 mmol) in anhydrous DMF (3 mL) was added 
dropwise to the mixture. Stirring was continued at room temperature for another 1 hour, followed 
by addition of tert-butyl mercaptan (1 mL). The reaction mixture was stirred at room temperature 
for 30 minutes and quickly filtered. The solvent was removed under reduced pressure and the 
residue was dissolved in ethyl acetate and washed with brine (3 × 50 mL). The combined organic 
layers were dried over Na2SO4 and filtered. The filtrate was concentrated to dryness under reduced 
pressure and the residue was purified by silica gel column chromatography with 
dichloromethane/methanol (30:1), yielding Compound 31 (561mg, 65%) as a white solid. 1H NMR 
(400 MHz, Chloroform-d) δ 8.83 (s, 1H), 8.12 (s, 1H), 6.24 (dd, J = 8.5, 5.4 Hz, 1H), 4.90 (d, J = 
11.3 Hz, 1H), 4.80 (d, J = 11.2 Hz, 1H), 4.53 (dt, J = 6.0, 1.8 Hz, 1H), 4.22 (q, J = 2.2 Hz, 1H), 
3.95 (dd, J = 11.4, 2.4 Hz, 1H), 3.85 (dd, J = 11.4, 2.3 Hz, 1H), 2.54 (ddd, J = 13.6, 5.5, 1.5 Hz, 
1H), 2.12 – 1.95 (m, 1H), 1.35 (s, 9H), 0.97 (s, 9H), 0.19 (d, J = 4.9 Hz, 6H). 13C NMR (75 MHz, 
Chloroform-d) δ 160.29, 150.21, 144.68, 86.29, 85.90, 81.09, 78.20, 68.87, 64.00, 48.05, 38.79, 




Compound 31 (501 mg, 0.83 mmol), CuI (20 mg, 0.11 mmol) and triethylamine (0.3 mL, 
2.16 mmol) in dry DMF (5 mL) were stirred under nitrogen in the dark for 5 minutes, followed by 
the addition of Compound 27 (277 mg, 0.92 mmol) and Pd(PPh3)4 (150 mg, 0.13 mmol). The 
mixture was stirred at room temperature in the dark overnight, then poured into brine (200 mL) 
with vigorous stirring and extracted with ethyl acetate (3 × 50 mL).  The organic layer was dried 
over Na2SO4, filtered and concentrated to dryness under reduced pressure to afford the crude 
product, Compound 32. 
Compound 33 
Crude compound 32 was dissolved in tetrahydrofuran (10 mL), TBAF (1.0M, 1.04 mL) 
was added in small portions, and the solution stirred at room temperature for 4 hours. The reaction 
mixture was poured into a saturated sodium bicarbonate solution (50 mL) and extracted with 
dichloromethane (3 × 50 mL).  The combined organic layers were dried over Na2SO4 and filtered. 
The filtrate was concentrated to dryness under reduced pressure and the residue of the desired 
compound was purified by silica gel column chromatography (dichloromethane/methanol, 95:5), 
to give Compound 33 (161 mg, 26% from 31). 1H NMR (400 MHz, Chloroform-d) δ 8.50 (s, 1H), 
8.11 (s, 1H), 7.45 (s, 1H), 6.22 (dd, J = 7.6, 6.0 Hz, 1H), 4.93 – 4.85 (m, 3H), 4.81 (d, J = 11.2 Hz, 
1H), 4.58 (dq, J = 6.3, 3.1 Hz, 1H), 4.52 (s, 2H), 4.20 (q, J = 2.7 Hz, 1H), 4.02 (ddd, J = 11.9, 4.3, 
2.5 Hz, 1H), 3.89 (ddd, J = 11.8, 5.0, 2.7 Hz, 1H), 3.50 (d, J = 6.3 Hz, 2H), 2.76 (t, J = 4.7 Hz, 
1H), 2.54 (ddd, J = 13.8, 6.0, 2.8 Hz, 1H), 2.25 (ddd, J = 13.8, 7.6, 6.4 Hz, 1H), 1.37 (s, 9H), 1.34 
(s, 6H). 13C NMR (75 MHz, Chloroform-d) δ 162.00, 158.47, 157.99, 149.59, 144.64, 118.29, 
114.47, 99.27, 87.93, 86.84, 85.66, 81.24, 80.62, 78.95, 77.70, 62.54, 57.67, 53.82, 50.82, 48.03, 
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47.41, 38.52, 31.95, 30.28, 25.97, 25.66, 23.01, 14.48, 11.79. HRMS (ESI+) calc’d for:  
C24H35F3N3O7S4 [(M+H)+]:662.1310, found: 662.1309. 
3’-O-tert-Butyldithiomethyl-dUTP-5-SS-NH2 (Compound 34) 
 Compound 33 (50 mg, 0.076 mmol), tributylammonium pyrophosphate (TBAP) (100 mg, 
0.18 mmol), and SalPCl (22 mg, 0.11 mmol) were dried separately over phosphorus pentoxide in 
vacuum desiccators at room temperature overnight. To a solution of SalPCl in anhydrous DMF (2 
mL) was added TBAP dissolved in anhydrous DMF (1 mL) and tributylamine (1 mL) at room 
temperature under argon. The mixture was stirred for 1 hour at room temperature, then added to 
the solution of Compound 33 in DMF (1 mL) and was stirred for another 1 hour at room 
temperature. Subsequently, iodine solution (0.02 M iodine/pyridine/water) was added until the 
mixture turned a permanent brown color. The solution was further stirred for 10 minutes, followed 
by addition of water (30mL) and another 2 hours of stirring. The reaction mixture was then washed 
with ethyl acetate (2 × 30 mL). The aqueous layer was concentrated in vacuo to approximately 20 
mL, then concentrated NH4OH (20 ml) was added and the solution was stirred overnight at room 
temperature. The aqueous layer was concentrated in vacuo and diluted with 5 ml of water, followed 
by purification by anion exchange chromatography on DEAE-Sephadex A-25 at 4°C using a 
gradient of TEAB (pH 8.0; 0.1–1.0 M). The crude product was further purified by reverse-phase 
HPLC to afford Compound 34.  HRMS (ESI-) calc’d for C22H38N3O15P3S4: 804.0320, found: 
804.0335. 
3’-O-tert-Butyldithiomethyl-dUTP-5-SS-R6G (Compound 35) 
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To a stirred solution of R6G-NHS ester (2 mg, 3.6µmol) in DMF (0.2 ml) was added 
compound 34 (3.5 µmol) in NaHCO3/Na2CO3 buffer (pH 8.9, 0.1 M, 0.3 ml). The reaction mixture 
was stirred at room temperature for 3 hours in the dark, followed by purification by anion exchange 
chromatography on DEAE-Sephadex A-25 at 4°C using a gradient of TEAB (pH 8.0; 0.1–1.0 M). 
The crude product was further purified by reverse-phase HPLC to afford Compound 35. HRMS 
(ESI-) calc’d for:  C49H61N5O19P3S4- [(M-H)-]:1244.2057, found: 1244.2034. 
2.3.7 Synthesis of 3’-O-tert-Butyldithiomethyl-dCTP-5-SS-Alexa488 
 
Scheme 2-15 Synthesis of 3’-O-tert-butyldithiomethyl-dCTP-5-SS-Alexa488 
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N4-DMF-5-Iodo-5’-O-tert-Butyldimethylsilyl-2’-Deoxycytidine (Compound 37) 
To a mixture of 36 (1 g, 2.8 mmol) and imidazole (200 mg, 3 mmol) in dry DMF (15 mL) 
was added tert-butyldimethylsilyl chloride (450 mg, 3 mmol). The mixture was stirred at room 
temperature overnight. The solvent was removed and to the residue was added N, N-
dimethylformamide dimethyl acetal (1.5 mL) in dry DMF (10 mL). The mixture was stirred at 
room temperature for 10 hours, then poured into ice water (200mL) with stirring followed by 
suction filtration. The precipitate was washed with water and hexane, then dissolved in ethyl 
acetate and dried over Na2SO4. The solvent was removed under reduced pressure and the residue 
was purified by column chromatography (dichloromethane/methanol, 20:1) to give pure product 
37 (1.02 g, 69%). 1H NMR (400 MHz, Chloroform-d) δ 8.74 – 8.69 (m, 1H), 8.27 (s, 1H), 6.37 
(dd, J = 7.8, 5.6 Hz, 1H), 4.46 (dt, J = 5.2, 2.3 Hz, 1H), 4.16 (q, J = 2.6 Hz, 1H), 3.94 (dd, J = 
11.3, 2.8 Hz, 1H), 3.84 (dd, J = 11.3, 2.7 Hz, 1H), 3.25 – 3.16 (m, 6H), 2.69 (ddd, J = 13.5, 5.7, 
2.3 Hz, 1H), 2.05 (ddd, J = 13.5, 7.8, 5.7 Hz, 1H), 0.93 (s, 9H), 0.15 (d, J = 8.9 Hz, 6H). 13C 
NMR (75 MHz, Chloroform-d) δ 169.14, 159.13, 156.11, 147.21, 88.36, 87.76, 72.71, 69.79, 
64.03, 42.95, 41.77, 35.84, 26.53, 18.79, -4.83 (d, J = 14.0 Hz). HRMS (ESI+) calc’d for:  
C18H32IN4O4Si [(M+H) +]:523.1238, found: 523.1232. 
N4-DMF-5-Iodo-5’-O-tert-Butyldimethylsilyl-3’-O-Methylthiomethyl-2’-Deoxycytidine 
(Compound 38) 
To a solution of Compound 37 (1.02g, 1.9 mmol) in DMSO (10 mL) with stirring was 
added acetic acid (2.3 mL, 40 mmol) and acetic anhydride (6.1 mL, 64mmol). The reaction 
mixture was stirred at room temperature for 2 days, then poured into a solution of saturated 
sodium bicarbonate with stirring and extracted with ethyl acetate (3 × 50 mL). The obtained 
 80 
crude product was dried over Na2SO4, solvents removed under reduced pressure, and purified by 
column chromatography (dichloromethane/methanol, 30:1) to give pure Compound 38 (1047 
mg, 92%).1H NMR (400 MHz, Chloroform-d) δ 8.74 (s, 1H), 8.22 (s, 1H), 6.28 (dd, J = 7.9, 5.6 
Hz, 1H), 4.70 (d, J = 11.7 Hz, 1H), 4.61 (d, J = 11.6 Hz, 1H), 4.48 (dt, J = 6.1, 2.3 Hz, 1H), 4.17 
(q, J = 2.7 Hz, 1H), 3.97 – 3.88 (m, 1H), 3.82 (dd, J = 11.2, 2.8 Hz, 1H), 3.27 – 3.16 (m, 6H), 
2.68 (ddd, J = 13.6, 5.7, 2.1 Hz, 1H), 2.16 (s, 3H), 1.97 (ddd, J = 13.8, 7.9, 6.1 Hz, 1H), 0.95 (d, 
J = 2.8 Hz, 9H), 0.22 – 0.13 (m, 6H).  
N4-DMF-5-Iodo-5’-O-tert-Butyldimethylsilyl-3’-O-(tert-Butyldithiomethyl)-2’-
Deoxycytidine (Compound 39) 
Compound 38 (1047 mg, 2 mmol) was dissolved in anhydrous dichloromethane (20 mL), 
followed by addition of triethylamine (0.3 mL, 2.16 mmol) and molecular sieves (3 Å, 2 g). The 
mixture was cooled in an ice bath after stirring at room temperature for 30 minutes and then a 
solution of freshly distilled sulfuryl chloride (0.16 mL, 2 mmol) in anhydrous dichloromethane (3 
mL) was added dropwise. The ice bath was removed and the reaction mixture was stirred for 
another 30 minutes. Then potassium p-toluenethiosulfonate (614 mg, 2.7 mmol) in anhydrous 
DMF (3 mL) was added to the mixture. Stirring was continued at room temperature for another 1 
hour, followed by addition of tert-butyl mercaptan (1 mL). The reaction mixture was stirred at 
room temperature for 30 minutes and quickly filtered. The solvent was removed under reduced 
pressure and the residue was dissolved in dichloromethane and washed with brine (3 × 50 mL). 
The combined organic layers were dried over Na2SO4 and filtered. The filtrate was concentrated 
to dryness under reduced pressure and the residue was purified by silica gel column 
chromatography (dichloromethane/methanol, 30:1), yielding Compound 39 (648, 56%). 1H NMR 
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(500 MHz, Chloroform-d) δ 8.73 (s, 1H), 8.22 (s, 1H), 6.27 (dd, J = 8.1, 5.5 Hz, 1H), 4.91 (d, J = 
11.2 Hz, 1H), 4.76 (d, J = 11.2 Hz, 1H), 4.51 (dt, J = 6.0, 2.0 Hz, 1H), 4.21 (q, J = 2.4 Hz, 1H), 
3.94 (dd, J = 11.3, 2.7 Hz, 1H), 3.83 (dd, J = 11.3, 2.6 Hz, 1H), 3.22 (d, J = 0.7 Hz, 3H), 3.18 (s, 
3H), 2.71 (ddd, J = 13.8, 5.6, 1.8 Hz, 1H), 1.95 (ddd, J = 13.9, 8.1, 6.0 Hz, 1H), 1.34 (s, 9H), 0.94 
(s, 9H), 0.17 (d, J = 7.6 Hz, 6H). HRMS (ESI+) calc’d for: C23H42IN4O4S2Si [(M+H)+]:657.1461, 
found: 657.1458. 
Compound 40 
Compound 39 (420 mg, 0.62 mmol), CuI (20 mg, 0.11 mmol) and triethylamine (0.3 mL, 
2.16 mmol) in dry DMF (5 mL) were stirred under nitrogen in the dark for 5 minutes, followed by 
the addition of Compound 27 (213 mg, 0.71 mmol) and Pd(PPh3)4 (150 mg, 0.13 mmol). The 
mixture was stirred at room temperature in the dark overnight, then poured into brine (200 mL) 
with vigorous stirring and extracted with ethyl acetate (3 × 50 mL).  The organic layer was dried 
over Na2SO4, filtered and concentrated to dryness under reduced pressure to afford the crude 
product Compound 40.  
Compound 41 
Crude Compound 40 was dissolved in tetrahydrofuran (10 mL), TBAF (1.0M, 1 mL) was 
added in small portions, and the solution was stirred at room temperature for 4 hours. The reaction 
mixture was poured into a saturated sodium bicarbonate solution (50 mL) and extracted with 
dichloromethane (3 × 50 mL).  The combined organic layers were dried over Na2SO4 and filtered. 
The filtrate was concentrated to dryness under reduced pressure and the residue of the desired 
compound was purified by silica gel column chromatography (dichloromethane/methanol, 20:1), 
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to give Compound 41 (146 mg, 32% from 39). 1H NMR (400 MHz, Chloroform-d) δ 8.77 (s, 1H), 
8.09 (s, 1H), 7.44 (t, J = 6.4 Hz, 1H), 6.11 (t, J = 6.6 Hz, 1H), 4.95 (s, 2H), 4.87 (d, J = 11.1 Hz, 
1H), 4.76 (d, J = 11.1 Hz, 1H), 4.55 (dt, J = 6.5, 3.2 Hz, 1H), 4.52 (s, 2H), 4.18 (q, J = 3.0 Hz, 
1H), 3.98 (dd, J = 12.0, 2.7 Hz, 1H), 3.84 (dd, J = 12.1, 3.3 Hz, 1H), 3.47 (d, J = 6.4 Hz, 2H), 3.18 
(d, J = 2.7 Hz, 6H), 2.59 (ddd, J = 13.8, 6.1, 3.2 Hz, 1H), 2.35 (dt, J = 13.7, 6.8 Hz, 1H), 1.33 (s, 
9H), 1.31 (s, 6H). HRMS (ESI+) calc’d for: C27H41F3N5O6S4Si [(M+H)+]:716.1891, found: 
716.1888. 
3’-O-tert-Butyldithiomethyl-dCTP-5-SS-NH2 (Compound 42) 
Compound 41 (50 mg, 0.07 mmol), tributylammonium pyrophosphate (TBAP) (99 mg, 
0.18 mmol), and SalPCl (22 mg, 0.11 mmol) were dried separately over phosphorus pentoxide in 
vacuum desiccators at room temperature overnight. To a solution of SalPCl in anhydrous DMF (2 
mL) was added TBAP dissolved in anhydrous DMF (1 mL) and tributylamine (1 mL) at room 
temperature under argon. The mixture was stirred for 1 hour at room temperature, then added to 
the solution of Compound 41 in DMF (1mL) and was stirred for another 1 hour at room 
temperature. Subsequently, iodine solution (0.02 M iodine/pyridine/water) was added until the 
mixture turned a permanent brown color. The solution was further stirred for 10 minutes, followed 
by addition of water (30mL) and another 2 hours of stirring. The reaction mixture was then washed 
with ethyl acetate (2 × 30mL). The aqueous layer was concentrated in vacuo to 20 mL. Then 
concentrated NH4OH (20 ml) was added and the solution stirred overnight at room temperature. 
The solution was concentrated in vacuo and the residue was diluted with 5ml of water, followed 
by purification by anion exchange chromatography on DEAE-Sephadex A-25 at 4°C using a 
gradient of TEAB (pH 8.0; 0.1–1.0 M). The crude product was further purified by reverse-phase 
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HPLC to afford Compound 42. HRMS (ESI-) calc’d for C22H39N4O14P3S4: 803.0480, found: 
803.0457.  
3’-O-tert-Butyldithiomethyl-dCTP-5-SS-Alexa488 (Compound 43) 
To a stirred solution of Alexa488-NHS ester (2 mg, 3.1µmol) in DMF (0.2 ml) was added 
Compound 42 (3 µmol) in NaHCO3/Na2CO3 buffer (pH 8.9, 0.1 M, 0.3 ml). The reaction mixture 
was stirred at room temperature for 3 hours in the dark, followed by purification by anion exchange 
chromatography on DEAE-Sephadex A-25 at 4°C using a gradient of TEAB (pH 8.0; 0.1–1.0 M). 
The crude product was further purified by reverse-phase HPLC to afford Compound 43. HRMS 
(MALDI+) calc’d for: C43H52N6O24P3S6 [(M+H)+]:1321.056, found: 1321.054. 
2.3.8 Synthesis of 3’-O-tert-Butyldithiomethyl-dATP-7-SS-ROX 
 
Scheme 2-16 Synthesis of 3’-O-tert-butyldithiomethyl-dATP-7-SS-ROX. 
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N6-DMF-7-Deaza-7-Iodo-5’-O-tert-Butyldimethylsilyl-2’-Deoxyadenosine (Compound 45) 
To a mixture of Compound 44 (1g, 2.65mmol) and imidazole (200 mg, 2.9 mmol) in dry 
DMF (15 mL) was added tert-butyldimethylsilyl chloride (440 mg, 2.9 mmol). The mixture was 
stirred at room temperature overnight. The solvent was removed and to the residue was added N,N-
dimethylformamide dimethyl acetal (1.5 mL) in dry DMF (10 mL). The mixture was stirred at 
room temperature for an 10 additional hours, then the mixture was poured into ice water (200mL) 
with stirring followed by suction filtration. The precipitate was washed with water and hexane, 
then dissolved in ethyl acetate and dried over Na2SO4. The solvent was removed under reduced 
pressure and the residue was purified by column chromatography (dichloromethane/methanol, 
20:1) to give pure product, Compound 45, (1.15 g, 79%). 1H NMR (500 MHz, Chloroform-d) δ 
8.76 (s, 1H), 8.42 (s, 1H), 7.51 (s, 1H), 6.81 – 6.71 (m, 1H), 4.60 (tt, J = 7.0, 3.7 Hz, 1H), 4.08 
(q, J = 3.2 Hz, 1H), 3.89 – 3.80 (m, 2H), 3.31 (d, J = 0.6 Hz, 3H), 3.18 (s, 3H), 2.51 – 2.37 (m, 
2H), 0.94 (s, 9H), 0.15 – 0.11 (d, J=13.4 Hz, 6H).  13C NMR (126 MHz, Chloroform-d) δ 160.49, 
156.88, 155.93, 151.97, 151.55, 150.88, 127.80, 126.30, 111.31, 86.83, 86.66, 83.60, 83.38, 72.68, 
72.52, 63.90, 63.82, 53.14, 41.79, 41.50, 40.90, 35.42, 26.06, 18.45, -5.25, -5.27, -5.44. HRMS 
(ESI+) calc’d for: C20H33IN5O3Si [(M+H)+]:546.1397, found: 546.1393. 
N6-DMF-7-Deaza-7-Iodo-5’-O-tert-Butyldimethylsilyl-3’-O-Methylthiomethyl-2’-
Deoxyadenosine (Compound 46) 
To a solution of Compound 45 (1.32g, 2.43 mmol) in DMSO (10 mL) with stirring was 
added acetic acid (3 mL, 52 mmol) and acetic anhydride (8 mL, 84 mmol). The reaction mixture 
was stirred at room temperature for 2 days, then poured into a solution of saturated sodium 
bicarbonate with stirring and the precipitate was collected by suction filtration, followed by 
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washing with water and hexanes. The obtained crude product was dissolved in dichloromethane 
and dried over Na2SO4.  The solvent was then removed under reduced pressure, and the residue 
was purified by column chromatography (dichloromethane/methanol, 30:1) to give pure product, 
Compound 46 (956 mg, 65%), as a white solid. 1H NMR (400 MHz, Chloroform-d) δ 8.80 (s, 1H), 
8.45 (s, 1H), 7.48 (s, 1H), 6.70 (dd, J = 7.7, 6.2 Hz, 1H), 4.77 – 4.64 (m, 2H), 4.61 (dt, J = 5.5, 2.8 
Hz, 1H), 4.14 (td, J = 3.8, 2.3 Hz, 1H), 3.83 (d, J = 3.8 Hz, 2H), 3.32 (d, J = 0.6 Hz, 3H), 3.19 (s, 
3H), 2.54 – 2.42 (m, 2H), 2.19 (s, 3H), 0.97 (s, 9H), 0.15 (d, J = 6.3 Hz, 6H). 
N6-DMF-7-Deaza-7-Iodo-5’-O-tert-Butyldimethylsilyl-3’-O-(tert-Butyldithiomethyl)-2’-
Deoxyadenosine (Compound 47) 
Compound 46 (900 mg, 1.49 mmol) was dissolved in anhydrous dichloromethane (20 mL), 
followed by addition of triethylamine (0.3 mL, 2.16 mmol) and molecular sieves (3 Å, 2 g). The 
mixture was cooled in an ice bath after stirring at room temperature for 30 minutes and then a 
solution of freshly distilled sulfuryl chloride (0.13 mL, 1.63 mmol) in anhydrous dichloromethane 
(3 mL) was added dropwise. The ice bath was removed and the reaction mixture was stirred for 
another 30 minutes. Then potassium p-toluenethiosulfonate (509 mg, 2.25 mmol) in anhydrous 
DMF (3 mL) was added to the mixture. Stirring was continued at room temperature for another 1 
hour, followed by addition of tert-butyl mercaptan (1 mL). The reaction mixture was stirred at 
room temperature for 30 minutes and quickly filtered through Celite. The filter was washed with 
dichloromethane and the organic fraction was concentrated. The residue was purified by silica gel 
column chromatography (dichloromethane/methanol, 30:1), yielding Compound 47 (733 mg, 
73%). 1H NMR (500 MHz, Chloroform-d) δ 8.80 (s, 1H), 8.45 (s, 1H), 7.51 (s, 1H), 6.69 (dd, J = 
8.1, 5.9 Hz, 1H), 4.90 (d, J = 11.2 Hz, 1H), 4.84 (d, J = 11.1 Hz, 1H), 4.63 (dt, J = 5.2, 2.4 Hz, 
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1H), 4.20 – 4.15 (m, 1H), 3.89 – 3.80 (m, 2H), 3.32 (s, 3H), 3.19 (s, 3H), 2.57 – 2.41 (m, 2H), 1.36 
(s, 9H), 0.98 (s, 9H), 0.16 (d, J = 7.9 Hz, 6H). 13C NMR (126 MHz, Chloroform-d) δ 160.37, 
155.85, 151.78, 151.23, 127.62, 111.28, 84.54, 83.54, 80.63, 78.00, 63.60, 53.16, 47.48, 40.89, 
38.19, 35.40, 29.93, 26.10, 18.47, -5.21, -5.40. HRMS (ESI+) calc’d for: C25H43IN5O3S2Si 
[(M+H)+]:680.1621, found: 680.1622.   
Compound 48 
Compound 47 (444 mg, 0.65 mmol), CuI (20 mg, 0.11 mmol) and triethylamine (0.3 mL, 
2.16 mmol) in dry DMF ( 5 mL) were stirred under nitrogen in the dark for 5 minutes, followed 
by the addition of Compound 27 (310 mg, 1.03 mmol) and Pd(PPh3)4 (150 mg, 0.13 mmol). The 
mixture was stirred at room temperature in the dark overnight, then poured into brine (200 mL) 
with vigorous stirring and extracted with ethyl acetate (3 × 50 mL).  The organic layer was dried 
over Na2SO4, filtered and concentrated to dryness under reduced pressure to afford the crude 
product Compound 48. 
Compound 49 
The crude compound 48 was dissolved in tetrahydrofuran (10 mL). TBAF (1.0M, 1 mL) 
was added in small portions, and the solution stirred at room temperature until the reaction was 
complete, which was monitored by TLC. The reaction mixture was poured into a saturated sodium 
bicarbonate solution (50 mL) and extracted with dichloromethane (3 × 50 mL).  The combined 
organic layers were dried over Na2SO4 and filtered. The filtrate was concentrated to dryness under 
reduced pressure and the residue of the desired compound was purified by silica gel column 
chromatography (dichloromethane/methanol, 20:1), to give Compound 49 (105 mg, 22% from 47). 
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1H NMR (400 MHz, Chloroform-d) δ 8.81 (d, J = 6.9 Hz, 1H), 8.41 (d, J = 9.6 Hz, 1H), 7.28 (s, 
1H), 6.13 (dd, J = 9.6, 5.5 Hz, 1H), 4.98 (s, 2H), 4.88 (d, J = 3.3 Hz, 2H), 4.73 (d, J = 5.3 Hz, 1H), 
4.58 (s, 2H), 4.33 (d, J = 4.9 Hz, 1H), 4.01 (dt, J = 13.2, 3.1 Hz, 1H), 3.83 (d, J = 8.1 Hz, 1H), 
3.48 (d, J = 6.4 Hz, 2H), 3.23 (d, J = 17.1 Hz, 6H), 3.13 – 3.00 (m, 1H), 2.40 (dt, J = 13.4, 6.7 Hz, 
1H), 1.37 (s, 9H), 1.33 (s, 6H), 0.94 – 0.83 (m, 1H). 13C NMR (75 MHz, Chloroform-d ) δ 162.23, 
158.17, 157.08, 152.13, 151.48, 150.16, 131.12, 113.22, 96.29, 90.20, 86.94, 84.09, 82.11, 81.09, 
80.16, 79.55, 64.07, 57.57, 51.02, 47.91, 47.28, 41.36, 37.94, 35.91, 35.34, 30.33, 26.01. HRMS 
(ESI+) calc’d for: C29H42F3N6O5S4 [(M+H)+]:739.2051, found: 739.2039. 
7-Deaza-3’-O-tert-Butyldithiomethyl-dATP-7-SS-NH2 (Compound 50) 
Compound 49 (40 mg, 0.054 mmol), tributylammonium pyrophosphate (TBAP) (60 mg, 0.109 
mmol), and SalPCl (22 mg, 0.11 mmol) were dried separately over phosphorus pentoxide in 
vacuum desiccators at room temperature overnight. To a solution of SalPCl in anhydrous DMF (2 
mL) was added TBAP dissolved in anhydrous DMF (1 mL) and tributylamine (1 mL) at room 
temperature under argon. The mixture was stirred for 1 hour at room temperature, then added to 
the solution of Compound 49 in DMF (1mL) and was stirred for another 1 hour at room 
temperature. Subsequently, iodine solution (0.02 M iodine/pyridine/water) was added until the 
mixture turned a permanent brown color. The solution was further stirred for 10 minutes, followed 
by addition of water (30mL) and another 2 hours of stirring. The reaction mixture was then washed 
with ethyl acetate (2 × 30mL). The aqueous layer was concentrated in vacuo to 20 mL. 
Concentrated NH4OH (20 ml) was added and stirring continuted overnight at room temperature. 
The solution was concentrated in vacuo and the residue was diluted with 5ml of water, followed 
by purification by anion exchange chromatography on DEAE-Sephadex A-25 at 4°C using a 
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gradient of TEAB (pH 8.0; 0.1–1.0 M). The crude product was further purified by reverse-phase 
HPLC to afford Compound 50. HRMS (ESI-) calc’d for C24H40N5O13P3S4: 826.0640, found: 
826.0621.  
3’-O-tert-Butyldithiomethyl-dATP-7-SS-ROX (Compound 51) 
To a stirred solution of ROX-NHS ester (2 mg, 3.2 µmol) in DMF (0.2 ml) was added 
compound 50 (3 µmol) in NaHCO3/Na2CO3 buffer (pH 8.9, 0.1 M, 0.3 ml). The reaction mixture 
was stirred at room temperature for 3h in the dark, followed by purification by anion exchange 
chromatography on DEAE-Sephadex A-25 at 4°C using a gradient of TEAB (pH 8.0; 0.1–1.0 M). 
The crude product was further purified by reverse-phase HPLC to afford Compound 51. HRMS 
(MALDI+) calc’d for: C57H69N7O17P3S4+ [(M+H)+]:1344.286, found: 1344.284. 
2.3.9 Synthesis of 3’-O-tert-Butyldithiomethyl-dGTP-7-SS-Cy5 
 
Scheme 2-17 Synthesis of 3’-O-tert-butyldithiomethyl-dGTP-7-SS-Cy5. 
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N2-DMF-7-Deaza-7-Iodo-5’-O-tert-Butyldimethylsilyl-2’-Deoxyguanosine (Compound 53) 
To a mixture of Compound 52 (1g, 2.6 mmol) and imidazole (202 mg, 2.9 mmol) in dry 
DMF (15 mL) was added tert-butyldimethylsilyl chloride (420 mg, 2.8 mmol). The mixture was 
stirred at room temperature overnight. The solvent was removed and to the residue was added N, 
N-dimethylformamide dimethyl acetal (1.5 mL) in dry DMF (10 mL). The mixture was stirred at 
room temperature until the reaction was complete, which was monitored by TLC, then the mixture 
was poured into ice water (200mL) with stirring followed by suction filtration. The precipitate was 
washed with water and hexanes. The obtained crude product was dissolved in ethyl acetate and 
dried over Na2SO4. The solvent was then removed under reduced pressure and the residue was 
purified by column chromatography (dichloromethane/methanol, 20:1) to give pure product, 
Compound 53 (1.07 g, 75%). 1H NMR (400 MHz, Chloroform-d) δ 8.63 (s, 1H), 8.60 (s, 1H), 7.11 
(s, 1H), 6.63 (dd, J = 7.5, 6.3 Hz, 1H), 4.03 (dt, J = 4.7, 3.1 Hz, 1H), 3.88 (dd, J = 10.8, 3.2 Hz, 
1H), 3.79 (dd, J = 10.8, 4.7 Hz, 1H), 3.52 (s, 1H), 3.19 (s, 3H), 3.09 (d, J = 0.6 Hz, 3H), 2.53 – 
2.34 (m, 2H), 0.97 (s, 9H), 0.16 (d, J = 8.7 Hz, 6H). HRMS (ESI+) calc’d for: C20H33IN5O4Si 
[(M+H)+]:562.1346, found: 562.1354. 
N2-DMF-7-Deaza-7-Iodo-5’-O-tert-Butyldimethylsilyl-3’-O-Methylthiomethyl-2’-
Deoxyguanosine (Compound 54) 
To a solution of Compound 53 (0.95g, 1.7 mmol) in DMSO (10 mL) with stirring was 
added acetic acid (3 mL, 52 mmol) and acetic anhydride (8 mL, 84 mmol). The reaction mixture 
was stirred at room temperature for 2 days, then poured into a solution of saturated sodium 
bicarbonate with stirring and the precipitate was collected by suction filtration, followed by 
washing with water and hexanes. The obtained crude product was dissolved in dichloromethane 
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and dried over Na2SO4.  The solvent was then removed under reduced pressure, and the residue 
was purified by column chromatography (dichloromethane/methanol, 30:1) to give pure product 
Compound 54 (756 mg, 72%).1H NMR (400 MHz, Chloroform-d) δ 9.66 (s, 1H), 8.62 (s, 1H), 
7.11 (s, 1H), 6.64 – 6.52 (m, 1H), 4.76 – 4.64 (m, 2H), 4.59 (dt, J = 5.2, 2.6 Hz, 1H), 4.11 (ddd, J 
= 4.5, 3.2, 2.2 Hz, 1H), 3.86 – 3.72 (m, 2H), 3.18 (s, 3H), 3.11 (d, J = 0.7 Hz, 3H), 2.45 – 2.36 (m, 
2H), 2.19 (s, 3H), 0.97 (s, 9H), 0.15 (d, J = 6.0 Hz, 6H). HRMS (ESI+) calc’d for: C22H37IN5O4SSi 
[(M+H)+]:622.1380, found: 622.1384. 
N2-DMF-7-Deaza-7-Iodo-5’-O-tert-Butyldimethylsilyl-3’-O-(tert-Butyldithiomethyl)-2’-
Deoxyguanosine (Compound 55) 
Compound 54 (731 mg, 1.65 mmol) was dissolved in anhydrous dichloromethane (20 mL), 
followed by addition of triethylamine (0.3 mL, 2.16 mmol) and molecular sieves (3 Å, 2 g). The 
mixture was cooled in an ice bath after stirring at room temperature for 30 minutes and then a 
solution of freshly distilled sulfuryl chloride (0.11 mL, 1.37 mmol) in anhydrous dichloromethane 
(3 mL) was added dropwise. The ice bath was removed and the reaction mixture was stirred for 
another 30 minutes. Then potassium p-toluenethiosulfonate (417 mg, 1.84 mmol) in anhydrous 
DMF (3 mL) was added to the mixture. Stirring was continued at room temperature for another 1 
hour, followed by addition of tert-butyl mercaptan (1 mL). The reaction mixture was stirred at 
room temperature for 30 minutes and quickly filtered through Celite. The filter was washed with 
dichloromethane and the organic fraction was concentrated. The residue was purified by silica gel 
column chromatography with (dichloromethane/methanol, 30:1), yielding Compound 55 (508mg, 
63%) 1H NMR (500 MHz, Chloroform-d) δ 9.35 (s, 1H), 8.63 (s, 1H), 7.12 (s, 1H), 6.56 (dd, J = 
8.5, 5.8 Hz, 1H), 4.92 – 4.83 (m, 2H), 4.59 (dt, J = 6.0, 2.0 Hz, 1H), 4.15 (tt, J = 2.9, 1.8 Hz, 1H), 
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3.81 (qd, J = 11.0, 3.6 Hz, 2H), 3.20 (s, 3H), 3.11 (s, 3H), 2.50 – 2.35 (m, 2H), 1.36 (s, 9H), 0.98 
(s, 9H), 0.16 (d, J = 7.6 Hz, 6H).13C NMR (126 MHz, Chloroform-d) δ 159.57, 157.62, 155.48, 
149.88, 122.83, 104.09, 84.48, 83.01, 80.56, 78.56, 77.25, 63.76, 55.19, 47.57, 41.33, 38.29, 34.67, 
29.92, 26.09, 18.46, -5.22, -5.43. HRMS (ESI+) calc’d for: C25H43IN5O4S2Si [(M+H)+]:696.1570, 
found: 696.1573. 
Compound 56 
Compound 55 (471 mg, 0.68 mmol), CuI (20 mg, 0.11 mmol) and triethylamine (0.3 mL, 
2.16 mmol) in dry DMF (5 mL) were stirred under nitrogen in the dark for 5 minutes, followed by 
the addition of Compound 27 (300 mg, 0.99 mmol) and Pd(PPh3)4 (150 mg, 0.13 mmol). The 
mixture was stirred at room temperature in the dark overnight, then poured into brine (200 mL) 
with vigorous stirring and extracted with ethyl acetate (3 × 50 mL).  The organic layer was dried 
over Na2SO4, filtered and concentrated to dryness under reduced pressure to afford the crude 
product, Compound 56. 
Compound 57 
The crude compound 56 was dissolved in tetrahydrofuran (10 mL). TBAF (1.0M, 1 mL) 
was added in small portions, and the solution stirred at room temperature until the reaction was 
complete, which was monitored by TLC. The reaction mixture was poured into a saturated sodium 
bicarbonate solution (50 mL) and extracted with dichloromethane (3 × 50 mL).  The combined 
organic layers were dried over Na2SO4 and filtered. The filtrate was concentrated to dryness under 
reduced pressure and the residue of the desired compound was purified by silica gel column 
chromatography (dichloromethane/methanol, 20:1), to give Compound 57 (121 mg, 24% from 55). 
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1H NMR (400 MHz, Chloroform-d) δ 8.92 (s, 1H), 8.52 (s, 1H), 7.69 – 7.63 (m, 1H), 7.01 (s, 1H), 
6.24 – 6.15 (m, 1H), 4.99 (s, 2H), 4.89 (t, J = 10.9 Hz, 2H), 4.67 (s, 1H), 4.56 (s, 2H), 4.22 (s, 1H), 
4.07 – 3.99 (m, 1H), 3.91 (d, J = 12.1 Hz, 1H), 3.76 (t, J = 10.0 Hz, 1H), 3.51 (d, J = 6.1 Hz, 2H), 
3.20 (s, 3H), 3.07 (s, 3H), 2.85 (td, J = 15.0, 14.2, 7.1 Hz, 1H), 2.41 (dd, J = 13.8, 6.3 Hz, 1H). 
HRMS (ESI+) calc’d for: C29H42F3N6O6S4 [(M+H)+]:755.2001, found: 755.2003. 
7-Deaza-3’-O-tert-Butyldithiomethyl-dGTP-7-SS-NH2 (Compound 58) 
Compound 57 (40 mg, 0.053 mmol), tributylammonium pyrophosphate (TBAP) (89 mg, 
0.162 mmol), and SalPCl (22 mg, 0.11 mmol) were dried separately over phosphorus pentoxide in 
vacuum desiccators at room temperature overnight. To a solution of SalPCl in anhydrous DMF (2 
mL) was added TBAP dissolved in anhydrous DMF (1 mL) and tributylamine (1 mL) at room 
temperature under argon. The mixture was stirred for 1 hour at room temperature, then added to 
the solution of Compound 57 in DMF (1mL) and was stirred for another 1 hour at room 
temperature. Subsequently, iodine solution (0.02 M iodine/pyridine/water) was added until the 
mixture turned a permanent brown color. The solution was further stirred for 10 minutes, followed 
by addition of water (30 mL) and another 2 hours of stirring. The reaction mixture was then washed 
with ethyl acetate (2 × 30mL). The aqueous layer was concentrated in vacuo to 20 mL. Then 
concentrated NH4OH (20 ml) was added and stirring continued overnight at room temperature. 
The solution was concentrated in vacuo and the residue was diluted with 5ml of water, followed 
by purification by anion exchange chromatography on DEAE-Sephadex A-25 at 4°C using a 
gradient of TEAB (pH 8.0; 0.1–1.0 M). The crude product was further purified by reverse-phase 
HPLC to afford Compound 58. HRMS (ESI-) calc’d for C24H40N5O14P3S4: 842.0558, found: 
843.0573.  
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3’-O-tert-butyldithiomethyl-dGTP-7-SS-Cy5 (Compound 59) 
To a stirred solution of Cy5-NHS ester (2 mg, 3.2 µmol) in DMF (0.2 ml) was added 
Compound 58 (3 µmol) in NaHCO3/Na2CO3 buffer (pH 8.9, 0.1 M, 0.3 ml). The reaction mixture 
was stirred at room temperature for 3 h in the dark, followed by purification by anion exchange 
chromatography on DEAE-Sephadex A-25 at 4°C using a gradient of TEAB (pH 8.0; 0.1–1.0 M). 
The crude product was further purified by reverse-phase HPLC to afford Compound 59. MALDI-
TOF MS calc’d for C57H77N7O21P3S6-[(M+H)]: 1482.280, found: 1482.286.  
2.4 Results and Discussions 
2.4.1 Synthesis of 3’-O-tert-Butyldithiomethyl-dNTPs 
A set of unlabeled 3’-O-tert-butyldithiomethyl-dNTPs, which contain a tert-
butyldithiomethyl moiety reversibly blocking the 3’-OH but lack DTM linker or fluorescent tag 
on the base were first synthesized. Synthesis of four 3’-O-tert-butyldithiomethyl-dNTPs were 
carried out following the synthetic route outlined in Scheme 2-9 - Scheme 2-12. The detailed 
synthesis procedures were presented in section 2.3.1-2.3.4 respectively. 
 3’-O-tert-butyldithiomethyl-dNTPs will be used as chasing reagent in sequencing by 
synthesis applications. With no bulky fluorescent tag on the base, 3’-O-tert-butyldithiomethyl-
dNTPs are expected to be more efficiently extended than the fluorescent variants in the 
polymerase reaction. As will be described in Chapter 3, they can be added either concurrently or 
after the extension reaction with fluorescent NRTs to perform SBS. They are expected to be 
incorporated into the primers which are not extended with dye labeled NRTs such that nearly all 
the primers are incorporated with a reversible terminator. 
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To produce each of the following 3’-O-tert-Butyldithiomethyl-dNTPs (3’-O-tert-butyl-
dithiomethyl-dATP, 3’-O-tert-butyldithiomethyl-dCTP, 3’-O-tert-butyl-dithio-methyl-dGTP and 
3’-O-tert-butyldithiomethyl-dTTP), the corresponding nucleoside, with 5’-OH and exocyclic 
amine on the base on C, A and G protected, was treated with acetic acid, acetic anhydride and 
DMSO to introduce a methylthiomethyl group on the 3’-OH position, then the methylthiomethyl 
group was transformed into a tert-butyldithiomethyl group, and subsequently the protecting 
group on the 5’-OH position was removed and nucleoside triphosphorylation was performed. 
Each product was purified by column chromatography or high-performance liquid 
chromatography (HPLC), and characterized by 1H/13C nuclear magnetic resonance (NMR), high 
resolution mass spectrometry (HRMS) or/and matrix-assisted laser desorption/ionization of flight 
mass spectrometry (MALDI-TOF MS). The overall yield from the starting material to 3’-O-tert-
butyldithiomethyl thymidine (compound 4) was 25.74%. The overall yield from the starting 
material to N4-benzoyl-3’-O-tert-butyldithiomethyl-2’-deoxycytidine (compound 9) was 28.86%. 
The overall yield from the starting material to N6-benzoyl-3’-O-tert-butyldithiomethyl-2’-
deoxyadenosine (compound 14) was 22.88%. The overall yield from the starting material to N2-
iso-butyryl-3’-O- tert-butyldithiomethyl -2’-deoxyguanosine (compound 19) was 24.75%. 
2.4.2 Synthesis of DTM linker 
The DTM linker in sufficient quantities for attachment to the base of all four fluorescent 
reversible terminators was then prepared. The protocol involved the preparation of two segments 
of the O-dithiomethyl linker, 2, 2, 2-trifluoro-N-(2-mercapto-2-methylpropyl) acetamide and 
trimethyl (3-(methylthiomethoxy) prop-1-yn-1-yl) silane, and then conjugating them following 
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the synthetic route as outlined in Scheme 2-13. The detailed procedures are described in section 
2.3.5. 
One challenge we encountered was that when we first attempted to use propargyl alcohol 
to synthesize trimethyl (3-(methylthiomethoxy) prop-1-yn-1-yl) silane (compound 27), the 
intermediate methylthiomethyl propargyl ether was too volatile to purify. To overcome this 
difficult, we used 3-(trimethylsilyl) propargyl alcohol as the starting material, leading to 
trimethyl silane protected methylthiomethyl propargyl ether, which shows more favorable 
physical properties for separation. The silane protecting group was readily removed rendering an 
alkyne end ready for coupling to the base of the nucleoside. 
2.4.3 Synthesis of 3’-O-tert-butyldithiomethyl-dNTP-SS-Dye Analogues 
Four fluorescent reversible terminators 3’-O-tert-butyldithiomethyl-dNTP-SS-Dye 
analogues (3’-O-tert-butyldithiomethyl-dATP-7-SS-ROX, 3’-O-tert-butyldithiomethyl-dCTP-5-
SS-Alexa488, 3’-O-tert-butyldithiomethyl-dGTP-7-SS-Cy5 and 3’-O-tert-butyldithio-methyl-
dUTP-5-SS-R6G) were successfully synthesized. Each fluorescent reversible terminator contains 
cleavable DTM moieties at both the 3’-OH position and at the 5-position of the pyrimidine bases 
or 7-position of the purine bases. Synthesis of the four 3’-O-tert-butyldithiomethyl-dNTP-SS-
Dye compounds were carried out following the synthetic route outlined in Scheme 2-14 - 
Scheme 2-17. The detailed synthesis procedures were presented in section 2.3.6 - 2.3.9  
respectively. 
To produce each of the following 3’-O-tert-butyldithiomethyl-dNTP-SS-Dye analogues, 
the 5’-OH of the corresponding nucleoside, as well as the exocyclic amine on the base (C, A and 
G), was first protected. Then acetic acid, acetic anhydride and DMSO were used to introduce a 
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methylthiomethyl group at the 3’-OH position, followed by its transformation to a tert-
butyldithiomethyl group. The Sonogashira reaction was used to attach a protected DTM linker on 
the specific location of the base of the nucleoside. After removal of the protecting group on the 
5’-OH position, triphosphorylation was carried out leading to a 3’-O-DTM-dNTP with a free 
NH2 group at the distal end of the linker. Finally, 4 Dye-NHS esters were used to couple the 
specific dye to the NH2 group via an amide bond, yielding the target fluorescently labeled 
nucleotide reversible terminators. Intermediates were purified by column chromatography and 
characterized by 1H/13C/19F nuclear magnetic resonance (NMR), high resolution mass 
spectrometry (HRMS) or/and matrix-assisted laser desorption/ionization of flight mass 
spectrometry (MALDI-TOF MS). The final product was purified High-performance liquid 
chromatography (HPLC). The overall yield from the starting material to compound 33 (T) was 
9.90%. The overall yield from the starting material to compound 41 (C) was 11.38%. The overall 
yield from the starting material to compound 49 (A) was 8.16%. The overall yield from the 
starting material to compound 57 (G) was 8.25%.  All the 3’-O-tert-butyldithiomethyl-dNTP-SS-
Dye compounds are well characterized by high resolution mass spectrometry (HRMS) or matrix-
assisted laser desorption/ionization of flight mass spectrometry (MALDI-TOF MS). Observed 
results are consistent with the calculated masses, demonstrating a well-established synthetic 
procedure for such reversible terminators. 
2.4.4 Selection of the Fluorescent Dyes 
Selection of the four dyes, R6G, Alexa488, ROX and Cy5 was based on their well 
separated excitation and emission spectra, as shown in Table 2-1. This set or similar sets of dyes 
have been used successfully in the past for other fluorescent SBS methods in our lab and 
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elsewhere, and are compatible with the lasers and filters of common fluorescent microscopes and 
scanners. 
Dye Excitation Maximum (nm) Emission Maximum (nm) 
Alexa488 490 525 
R6G 528 551 
ROX 580 605 
Cy5 649 666 
Table 2-1 Approximate maximal excitation and emission 
wavelengths of R6G, Alexa488, ROX and Cy5. 
 
2.4.5 Summary 
The complete synthesis of a library of NRTs including four 3’-O-tert-butyldithiomethyl-
dNTPs (3’-O-tert-butyldithiomethyl-dATP, 3’-O-tert-butyldithiomethyl-dCTP, 3’-O-tert-butyl-
dithio-methyl-dGTP and 3’-O-tert-butyldithiomethyl-dTTP) and four 3’-O-tert-
butyldithiomethyl-dNTP-SS-Dye analogues (3’-O-tert-butyldithiomethyl-dATP-7-SS-ROX, 3’-
O-tert-butyldithiomethyl-dCTP-5-SS-Alexa488, 3’-O-tert-butyldithiomethyl-dGTP-7-SS-Cy5 
and 3’-O-tert-butyldithio-methyl-dUTP-5-SS-R6G) in sufficient yield and purity was 
accomplished to carry out the incorporation and cleavage tests and multiple actual sequencing 
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Chapter 3 oEvaluation of 3’-O-tert-Butyldithiomethyl-dNTPs and 3’-O-tert-
Butyldithiomethyl-dNTP-SS-Dye Analogues as Reversible Terminators for 
DNA Sequencing by Synthesis    
3.1 Introduction 
In this section, the potential to use the newly developed set of nucleotide analogues as 
fluorescent reversible terminators to conduct DNA sequencing by synthesis was explored. We 
first demonstrate these nucleotide analogues are good substrates for DNA polymerase; the dye as 
well as the 3’-tert-butyldithiomethyl group can be cleaved with high efficiency by adding a 
chemical reducing reagent (THP or TCEP) in aqueous solution; after cleavage, the SH residue 
can self-collapse into a stable OH group. Lab-scale DNA sequencing was then performed as a 
proof of principle, using a mixture of 3’-O-tert-butyldithiomethyl-dNTPs and 3’-O-tert-
butyldithiomethyl-dNTP-SS-Dye compounds to successfully identify ~ 30 continuous bases of 
DNA templates immobilized on a slide. The positive results demonstrated the feasibility of using 
the newly developed nucleotide analogue set in massively parallel sequencing by synthesis 
applications. 
3.2 Single-Base Extension Reactions of 3’-O-tert-Butyldithiomethyl-dNTP 
3.2.1 Experimental Rationale 
 3’-O-tert-butyldithiomethyl-dNTPs are the reversible terminators with a blocking moiety 
at the 3’ position but lacking a fluorescent dye or linker on the base. They serve as initial test 
molecules for the fluorescently labeled reversible terminators, and will be used along with the 
labeled nucleotide analogues as chase reagents in DNA sequencing by synthesis applications. 
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First, single-base extension reactions were conducted with 3’-O-tert-butyldithiomethyl-dNTPs 
alone, to investigate whether nucleotides modified with a 3’-O-tert-butyldithiomethyl group can 
be incorporated by DNA polymerase.  
Four separate single-base extension reactions were conducted in solution for each of the 
3’-O-tert-butyldithiomethyl-dNTPs (Figure 3-1). In each reaction, we added the corresponding 
template and primer (Figure 3-2), together with polymerase, a mixture all four of the of 3’-O-tert-
butyldithiomethyl-dNTPs (3’-O-tert-butyldithiomethyl-dATP, 3’-O-tert-butyldithiomethyl-dCTP, 
3’-O-tert-butyl-dithio-methyl-dGTP and 3’-O-tert-butyldithiomethyl-dTTP) and appropriate 
cofactors and buffer reagents. After the incorporation reaction, the products of each reaction were 
analyzed by MALDI-TOF MS to obtain the mass for comparison with the value calculated for the 
expected correctly extended primer.  
We expect to observe incorporation of the correct 3’-O-tert-butyldithiomethyl-dNTP in the 
polymerase reaction and that multiple incorporation events are effectively prevented. Detailed 





Figure 3-1 Scheme of single-base extension reactions of 3’-O-
tert-butyldithiomethyl-dNTPs. The example shown indicates 
extension by 3’-O-tert-butyldithiomethyl-dTTP. 
 
Figure 3-2 Templates and primers designed for single-base 
extension reactions. A single long template was used for the A, C, 
and T extension reactions. A separate template was used for the G 
extension reaction. Relevant positions of the template for each 
reaction are shown in the figure. For each 3’-O-tert-
butyldithiomethyl-dNTP, an appropriate template and primer were 
selected. Polymerase and a mixture of the four 3’-O-tert-
butyldithiomethyl-dNTPs were added together with the other 
components of the reaction. Templates are denoted in blue and 
primers were denoted in yellow. The next two incorporation 
positions are highlighted in red. 
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3.2.2 Results 
The mass of the expected incorporation product (the single base extended primer) for 3’-
O-tert-butyldithiomethyl-dATP is 6533, and the measured mass is 6534 (shown in Figure 3-3 A). 
The masses of the expected incorporation product for 3’-O-tert-butyldithiomethyl-dGTP is 6596, 
identical to the measured mass (shown in Figure 3-3 B). Similarly, the masses of the expected 
incorporation products for 3’-O-tert-butyldithiomethyl-dCTP and 3’-O-tert-butyldithiomethyl-
dTTP are 5569 and 5604 and the measured masses are 5569 and 5601 (shown in Figure 3-3 C and 
Figure 3-3 D). The difference between the measured and expected masses are within the resolution 
of MALDI-TOF MS, indicating that nucleotides modified with a 3’-O-tert-butyldithiomethyl 
group can be incorporated by DNA polymerase, and that the 3’-O-tert-butyldithiomethyl group 
can effectively prevent the addition of a second nucleotide.  This result verified nucleotides 








Figure 3-3 MALDI-TOF MS spectra of extension products for 
single-base extension reactions with 3’-O-tert-butyldithiomethyl-
dNTPs in solution. Primer extended with (A) 3’-O-tert-butyl-
dithiomethyl-dATP; (B) 3’-O-tert-butyldithiomethyl-dGTP; (C) 
3’-O-tert-butyldithiomethyl-dCTP; and (D) 3’-O-tert-butyl-
dithiomethyl-dTTP. The expected masses are denoted in 
parentheses. 
 
3.3 Continuous Incorporation and Cleavage Reactions of 3’-O-tert-Butyldithiomethyl-
dNTPs in Solution 
3.3.1 Experimental Rationale 
To verify that the terminating effect of 3’-O-tert-butyldithiomethyl modification is indeed 
“reversible”, i.e., the 3’-O-tert-butyldithiomethyl group can be cleaved with high efficiency under 
mild conditions in aqueous solution without hindering subsequent DNA polymerase activity, four 
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continuous cycles of DNA extension and cleavage reactions with 3’-O-tert-butyldithiomethyl 
nucleotide analogues were carried out in solution.  
 
Figure 3-4 Scheme of continuous extension and cleavage reactions 
for 3’-O-tert-butyldithiomethyl-dNTP analogues in solution. Four 
cycles, each for a different nucleotide, are indicated. 
 
One continuous incorporation and cleavage reaction containing four consecutive cycles 
was conducted (Figure 3-4). In each cycle, to a mixture of DNA templates and DNA primers the 
mixture of the four 3’-O-tert-butyldithiomethyl-dNTPs and polymerase together with other 
required reagents was added. After the incorporation reaction, the products were desalted and a 
small amount of the product was analyzed by MALDI-TOF MS and the observed mass compared 
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with the expected calculated value. The rest of the incorporation products were treated with tris(2-
hydroxypropyl)phosphine (THP) solution for cleavage. The cleavage products were diluted, 
desalted and a small amount was analyzed by MALDI-TOF MS. The rest of the cleavage products 
were used as primers in the subsequent polymerase extension and cleavage reaction. The same 
procedure was repeated 3 times to obtain results for 4 continuous incorporation and cleavage steps.  
We expected to observe incorporation of the correct 3’-O-tert-butyldithiomethyl-dNTP, 
that multiple addition would be effectively prevented in each cycle, and that subsequent 
incorporation would not be interfered with due to the cleavage reactions, i.e., that cleavage would 
restore the 3’-OH group for subsequent incorporation cycles. Detailed methods including primer 
and template sequences are provided in section 3.6.23.6.2. 
3.3.2 Results 
The expected mass of the primer extended with 3’-O-tert-butyldithiomethyl-dATP after 
the first incorporation product is 4407, and the observed mass was 4404 (Figure 3-5 A). The 
expected mass of the cleavage product is 4266, and the observed mass was 4272 (Figure 3-5 B). 
Extension of the cleaved primer with 3’-O-tert-butyldithiomethyl-dCTP is expected to display a 
mass of 4690, and the observed mass was 4697 (Figure 3-5 C). The expected mass of the cleavage 
product is 4549, and the observed mass was 4563 (Figure 3-5 D). Extension of this cleaved primer 
with 3’-O-tert-butyldithiomethyl-dGTP is expected to display a mass of 5013, and the observed 
mass was 5024 (Figure 3-5 E). The expected mass of the cleavage product is 4872, and the 
observed mass was 4888 (Figure 3-5 F). Extension of this cleaved primer with 3’-O-tert-
butyldithiomethyl-dTTP is expected to display a mass of 5311, and the observed mass was 5328 
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(Figure 3-5 G). The expected mass of the cleavage product is 5170, and the observed mass was 
5199 (Figure 3-5 H).  
The differences between expected and measured masses are within the resolution of 
MALDI-TOF MS. The results verified that the 3’-O-tert-butyldithiomethyl group can be cleaved 
with high efficiency by THP in aqueous solution and the next cycle of sequencing by synthesis is 
not affected after the regeneration of the 3’-OH group.  
Combining the results in sections 3.2 and 3.3, we conclude that the tert-butyldithiomethyl 
group can serve as a good reversible blocking group on the 3’ position of fluorescent nucleotide 
reversible terminators. With these encouraging results, we proceeded to the synthesis and testing 







Figure 3-5 MALDI-TOF MS spectra of extension and cleavage 
products for continuous extension and cleavage reactions of 3’-O-
DTM dNTPs in solution. Primer extended with 3’-O-tert-
butyldithiomethyl-dATP (A), and its cleavage product (B). 
Previous cleavage product further extended with 3’-O-tert-
butyldithiomethyl-dCTP (C), and its cleavage product (D). 
Previous cleavage product further extended with 3’-O-tert-
butyldithiomethyl-dGTP (E), and its cleavage product (F). 
Previous cleavage product further extended with 3’-O-tert-
butyldithiomethyl-dTTP (G), and its cleavage product (H). The 




























3.4 Single-Base Extension and Cleavage Reactions of 3’-O-tert-Butyldithiomethyl-
dNTP-SS-Dye Analogues in Solution 
3.4.1 Experimental Rationale 
To verify that the 3’-O-tert-butyldithiomethyl-dNTP-SS-Dye nucleotide analogues are 
good substrates for DNA polymerase in a solution-phase extension reaction, and that the 3’-O-
DTM group as well as the SS containing linker can be cleaved with high efficiency, single-base 
extension and cleavage reactions were conducted with each of the 3’-O-tert-butyldithiomethyl-
dNTP-SS-Dye compounds in solution. 
A separate single-base extension reaction in solution for each of the 3’-O-tert-
butyldithiomethyl-dNTP-SS-Dye compounds (Figure 3-6) was performed. In each reaction, we 
added the corresponding template and primer (Figure 3-2), together with polymerase, a mixture 
of 3’-O-tert-Butyldithiomethyl-dNTP-SS-Dye analogues (3’-O-tert-butyldithiomethyl-dATP-7-
SS-ROX, 3’-O-tert-butyldithiomethyl-dCTP-5-SS-Alexa488, 3’-O-tert-butyldithiomethyl-dGTP-
7-SS-Cy5 and 3’-O-tert-butyldithiomethyl-dUTP-5-SS-R6G) and other appropriate ingredients. 
After the incorporation reaction, the products of each reaction were desalted and a small amount 
of the incorporation product was analyzed by MALDI-TOF MS and the resulting mass compared 
with the expected calculated value. The rest of the incorporation products were treated with tris(2-
hydroxy-propyl)phosphine (THP) solution for cleavage and the cleavage products were diluted, 
desalted and a small amount analyzed by MALDI-TOF MS.  
We expected to observe incorporation of the correct 3’-O-tert-butyldithiomethyl-dNTP-
SS-Dye analogues and that multiple nucleotide addition woud be effectively prevented in each 
cycle. Further, if the cleavage was successful, both the 3’-O-DTM group as well as the SS linker 
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would be cleaved and the SH residue self-collapse into an OH group. Detailed methods including 
primer and template sequences are provided in section 3.6.3. 
 
 
Figure 3-6 Scheme of single-base extension and cleavage 
reactions for 3’-O-tert-butyldithiomethyl-dNTP-SS-Dye 
compounds in solution. The example shown indicates extension 




The mass of the expected incorporation products for 3’-O-tert-butyldithiomethyl-dATP-7-
SS-ROX is 7253, and the observed mass is 7251 (Figure 3-7 A). The mass of the corresponding 
cleavage products is 6451, and the observed mass is 6455 (Figure 3-7 B). The mass of the expected 
incorporation products for 3’-O-tert-butyldithiomethyl-dCTP-5-SS-Alexa488 is 6288, and the 
observed mass is 6285 (Figure 3-7 C). The mass of the corresponding cleavage products is 5488, 
and the observed mass is 5486 (Figure 3-7 D). The mass of the expected incorporation products 
for 3’-O-tert-butyldithiomethyl-dGTP-7-SS-Cy5 is 7438, and the observed mass is 7442 (Figure 
3-7 E). The mass of the corresponding cleavage products is 6515, and the observed mass is 6522 
(Figure 3-7 F). The mass of the expected incorporation products for 3’-O-tert-butyldithiomethyl-
dUTP-5-SS-R6G is 6221, and the observed mass is 6231 (Figure 3-7 G). The mass of the 
corresponding cleavage products is 5508, and the observed mass is 5511 (Figure 3-7 H).  
The expected versus observed measured masses are within the resolution of MALDI-TOF 
MS. The results verified that 3′-O-DTM-SS-Dye-dNTP analogues can be incorporated by DNA 
polymerase with high fidelity, the 3′-O-tert-butyldithiomethyl group as well as the linker can be 
cleaved with high efficiency by THP in aqueous solution, and the residue on the linker and the 3’ 
position of the sugar can self-collapse into a stable OH group. Through this experiment we 
confirmed that the 3’-O-tert-butyldithiomethyl-dNTP-SS-Dye analogues satisfied the 
requirements for a good set of fluorescent reversible terminators to facilitate sequencing by 
synthesis applications.  
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Figure 3-7 Results of single-base extension and cleavage reactions 
of 3’-O-tert-butyldithiomethyl-dNTP-SS-Dye analogues in 
solution. Primer extended with 3’-O-tert-butyldithiomethyl-dATP-
7-SS-ROX (A), and its cleavage product (B). Primer extended with 
3’-O-tert-butyldithiomethyl-dCTP-5-SS-Alexa488 (C), and its 
cleavage product (D). Primer extended with 3’-O-tert-
butyldithiomethyl-dGTP-7-SS-Cy5 (E), and its cleavage product 
(F). Primer extended with 3’-O-tert-butyldithiomethyl-dUTP-5-
SS-R6G (G), and its cleavage product (H). The expected masses 












3.5 Four-color SBS on Surface-Immobilized DNA with 3’-O-tert-Butyldithiomethyl-
dNTPs and 3’-O-tert-Butyldithiomethyl-dNTP-SS-Dye Analogues 
3.5.1 Experimental Rationale 
Finally, the use of the library of NRTs for actual fluorescent sequencing by synthesis with 
DNA templates attached to a solid support was investigated. A slide with immobilized self-priming 
DNA was constructed (Figure 3-8) to conduct four-color SBS using 3’-O-tert-butyldithiomethyl-
dNTPs and 3’-O-tert-butyldithiomethyl-dNTP-SS-Dye analogues.   
 
Figure 3-8 Construction of a slide with immobilized self-
priming DNA. Self-priming template was selected to prevent the 
dissociation of the primers from the template as would occur with 
linear template and primer molecules. 
 
As illustrated in Figure 3-9, the sequencing proceeded in cycles each consisting of 
extension, chasing and cleavage. A mixture of the four 3’-O-tert-butyldithiomethyl-dNTP-SS-Dye 
analogues was first added. Due to the existence of the capping moiety on the 3’-OH group, each 
extended primer was extended with only one nucleotide analogue, the one complementary to the 
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base at the next available position in the template. After washing, a four-color scanner was used 
to measure the fluorescent signal to identify the nucleotide added and to infer the nucleotide at that 
point in the template sequence. A synchronization reaction mixture consisting of the four 3’-O-
tert-butyldithiomethyl-dNTPs was then added. 3’-O-tert-butyldithiomethyl-dNTPs do not contain 
bulky fluorescent groups and have higher polymerase incorporation efficiency, and their role is to 
extend any remaining priming strand that still has a free 3’-OH group to ensure all extended 
templates are at the same place. After this chase step, THP solution was used to cleave both the 
fluorophore and the 3’-DTM group, regenerating the free 3’-OH group. After washing, four-color 
scanning can confirm the successful removal of the fluorescent tags, and the next cycle of 
sequencing can begin. The same procedure was repeated multiple times to obtain the sequence of 
the template.  
We expected to observe incorporation of the correct 3’-O-tert-butyldithiomethyl-dNTP-
SS-Dye molecule and successful cleavage at each consecutive position on the template. Detailed 





Figure 3-9 Scheme of four-color sequencing by synthesis on a 
DNA chip. (1) Incorporation of 3’-O-tert-butyldithiomethyl-
dATP-7-SS-ROX. (2) Cleavage of dye and 3’-O-tert-
butyldithiomethyl group. (3) Incorporation of 3’-O-tert-
butyldithiomethyl-dUTP-5-SS-R6G. (4) Cleavage of dye and 3’-O-
tert-butyldithiomethyl group. Additional cycles are represented by 
the line of arrows. 
3.5.2 Results 
Exemplary scanning and cleavage images for each 3’-O-tert-butyldithiomethyl-dNTP-SS-
Dye analogue is shown in Figure 3-10. The sequencing results for 3 different templates are shown 
in Figure 3-11, Figure 3-12 and Figure 3-13. Each template was tested twice to verify the 
reproducibility of the process. The laser excitation wavelengths of the scanner are 488nm, 546nm, 
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594nm and 647nm.  The intensity of the emitted fluorescence was measured and illustrated by the 
height of the bars.  
As shown by the results, the sequencing achieved a 100% accuracy over 28 cycles in all 
experiments, indicating the new set of fluorescent reversible terminators can be incorporated by 
the selected polymerase with high fidelity; even in regions with consecutive identical nucleotides, 
multiple addition did not occur, confirming the 3’ blocking moiety can successfully terminate the 
polymerase reaction; the subsequent sequencing was successfully resumed, indicating the cleavage 
strategy was successful and termination was indeed reversible. Overall, the new set of nucleotide 




Figure 3-10 Exemplary scanning and cleavage images for each 3’-
O-tert-butyldithiomethyl-dNTP-SS-Dye. Incorporation and 
cleavage of (1,2) 3’-O-tert-butyldithiomethyl-dUTP-5-SS-R6G; 







Figure 3-11 Four color SBS data on a solid surface. Sequence of 
self-priming Template #1 (top) with 28 base sequencing read. A 
four-color sequencing data plot of raw fluorescence emission 
intensity obtained by using a mixture of 3’-O-tert-
butyldithiomethyl-dATP-7-SS-ROX (orange), 3’-O-tert-
butyldithiomethyl-dCTP-5-SS-Alexa488 (blue), 3’-O-tert-
butyldithiomethyl-dGTP-7-SS-Cy5 (red), and 3’-O-tert-



















Figure 3-12 Four color SBS data on a solid surface. Sequence of 
self-priming Template #2 (top) with 28 base sequencing read. A 
four-color sequencing data plot of raw fluorescence emission 
intensity obtained by using a mixture of 3’-O-tert-
butyldithiomethyl-dATP-7-SS-ROX (orange), 3’-O-tert-
butyldithiomethyl-dCTP-5-SS-Alexa488 (blue), 3’-O-tert-
butyldithiomethyl-dGTP-7-SS-Cy5 (red), and 3’-O-tert-


















Figure 3-13 Four color SBS data on a solid surface. Sequence of 
self-priming Template #3 (top) with 28 base sequencing read. A 
four-color sequencing data plot of raw fluorescence emission 
intensity obtained by using a mixture of 3’-O-tert-
butyldithiomethyl-dATP-7-SS-ROX (orange), 3’-O-tert-
butyldithiomethyl-dCTP-5-SS-Alexa488 (blue), 3’-O-tert-















3.6 Detailed Methods 
3.6.1 Single-Base Extension Reactions for 3’-O-tert-Butyldithiomethyl-dNTP 
Polymerase extension reactions consisted of 20 pmol of a synthetic DNA template (Exon8 
template with sequence 5’-GAAGGAGACACGCGGCCAGAGAGGGTCCTGTCCGTGTTT 
GTGCGTGGAGTTCGACAAGGCAGGGTCATCTAATGGTGATGAGTCCTATCCTTTTCT
CTTCGTTCTCCGT-3’ for 3’-O-tert-butyldithiomethyl-dATP, 3’-O-tert-butyldithiomethyl-
dCTP and 3’-O-tert-butyldithiomethyl-dTTP, and Exon7 template with sequence 5’- 
TACCCGGAGGCCAAGTACGGCGGGTACGTCCTTGACAATGTGTACATCAACATCAC
CTACCACCATGTCAGTCTCGGTTGGATCCTCTATTGTGTCCGGG-3’ for 3’-O-tert-butyl-
dithiomethyl-dGTP), 3’-O-tert-butyldithiomethyl-dNTP mixtures (3’-O-tert-butyl dithiomethyl-
dATP, 3’-O-tert-butyldithiomethyl-dCTP, 3’-O-tert-butyldithiomethyl-dGTP and 3’-O-tert-
butyldithiomethyl-dTTP, 100 pmol each) and 60 pmol of primers (5’-TAGATGAC 
CCTGCCTTGTCG-3’ for 3’-O-tert-butyldithiomethyl-dATP, 5’-TCTCTGGCCGCGTGTCT-3’ 
for 3’-O-tert-butyldithiomethyl-dCTP, 5’-GTTGATGTACACATTGTCAA-3’ for 3’-O-tert-
butyldithiomethyl-dGTP and 5’-GATAGGACTCATCACCA-3’ for 3’-O-tert-butyl dithiomethyl-
dTTP),  1× ThermoPol reaction buffer (New England BioLabs, MA), 2 unit Therminator™ IX 
DNA polymerase (New England BioLabs, MA) and deionized H2O in a total volume of 20 µL. 
Reactions were conducted in a thermal cycler (MJ Research, MA). The extension reaction 
consisted of an initial incubation at 94 °C for 20 sec, followed by 36 cycles at 80°C for 20 sec, 
45°C for 40 sec, and 65°C for 90 sec. The DNA products were desalted using an Oligo Clean & 
Concentrator™ (Zymo Research, CA) and a small amount of the product was analyzed by 
MALDI-TOF MS (ABI Voyager, DE). 
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3.6.2 Continuous Extension and Cleavage Reactions of 3’-O-tert-Butyldithiomethyl-
dNTPs in Solution 
Polymerase extension reactions consisted of 20 pmol of a synthetic 51-mer DNA template 
(5’-GAGGCCAAGTACGGCGGGTACGTCCTTGACAATGTGTACATCAACATCACC-3’), 
60 pmol of primer (5’ -CACATTGTCAAGG-3’ ), 3’-O-tert-butyldithiomethyl-dNTP mixtures 
(3’-O-tert-butyldithiomethyl-dATP, 3’-O-tert-butyldithiomethyl-dCTP, 3’-O-tert-butyl-
dithiomethyl-dGTP and 3’-O-tert-butyldithiomethyl-dTTP, 100 pmol each),  1× ThermoPol 
reaction buffer (New England BioLabs, MA), 2 units Therminator™ IX DNA polymerase (New 
England BioLabs, MA) and deionized H2O in a total volume of 20 µL. Reactions were conducted 
in a thermal cycler (MJ Research, MA). The extension reaction consisted of an initial incubation 
at 94 °C for 20 sec, followed by 36 cycles at 80°C for 20 sec, 45°C for 40 sec, and 65°C for 90 
sec. The DNA products were desalted using an Oligo Clean & Concentrator™ (Zymo Research, 
CA)  and a small amount of product was analyzed by MALDI-TOF MS (ABI Voyager, DE).  
The remaining DNA product was concentrated under vacuum and purified by reverse phase 
HPLC on an XTerra MS C18, 2.5 µm 4.6 mm x 50 mm column (Waters, MA) to obtain the pure 
extension product. Mobile phase: A, 8.6 mM triethylamine/100 mM 1,1,1,3,3,3-hexafluoro-2-
propanol in water (pH 8.1); B, methanol. Elution was performed at 40 °C with a 0.5 mL/min flow 
rate, and from 88% A/12% B to 65.5% A/34.5% B linear gradient for 90 min.  100 pmol extension 
product was then dissolved in 10 µL 5mM tris(2-hydroxypropyl)phosphine (THP) solution (pH 5 
9.0). The mixture was incubated at 65 °C for 3 minutes, followed by dilution in 1 mL deionized 
water and desalting in an Amicon Ultra-0.5 centrifugal filter unit with Ultracel-3 membrane 
(Millipore). 2 µL DNA product were used to characterize the molecular weight information by 
MALDI-TOF mass spectrometry, and the rest of the cleavage products were used as primers in the 
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subsequent polymerase extension reaction. Three additional consecutive cycles were conducted 
using the same steps indicated above, with the scheme and results shown in Figure 3-4. 
3.6.3 Single-base Extension and Cleavage Reactions for 3’-O-tert-Butyldithiomethyl-
dNTP-SS-Dye Analogues in Solution 
Polymerase extension reactions consisted of 20 pmol of a synthetic DNA template (Exon8 
template with sequence 5’- GAAGGAGACACGCGGCCAGAGAGGGTCCTGTCCGTGTTT 
GTGCGTGGAGTTCGACAAGGCAGGGTCATCTAATGGTGATGAGTCCTATCCTTTTCT
CTTCGTTCTCCGT- 3’ for 3’-O-tert-butyldithiomethyl-dATP-7-SS-ROX, 3’-O-tert-butyl-
dithiomethyl-dCTP-5-SS-Alexa488, 3’-O-tert-butyldithiomethyl-dUTP-5-SS-R6G, and Exon7 
template with sequence 5’- TACCCGGAGGCCAAGTACGGCGGGTACGTCCTTGACAATGT 
GTACATCAACATCACCTACCACCATGTCAGTCTCGGTTGGATCCTCTATTGTGTCCGG
G-3’ for 3’-O-tert-butyldithiomethyl-dGTP-7-SS-Cy5), 3’-O-tert-butyldithiomethyl-dNTP-SS-
Dye mixtures (3’-O-tert-butyldithiomethyl-dATP-7-SS-ROX, 3’-O-tert-butyl dithiomethyl-
dCTP-5-SS-Alexa488, 3’-O-tert-butyldithiomethyl-dGTP-7-SS-Cy5 and 3’-O-tert-
butyldithiomethyl-dUTP-5-SS-R6G, 100 pmol each) and 60 pmol of primers (5’-
TAGATGACCCTGCCTTGTCG-3’ for 3’-O-tert-butyldithiomethyl-dATP-7-SS-ROX, 5’-
TCTCTGGCCGCGTGTCT-3’ for 3’-O-tert-butyldithiomethyl-dCTP-5-SS-Alexa488, 5’-
GTTGATGTACACATTGTCAA-3’ for 3’-O-tert-butyldithiomethyl-dGTP-7-SS-Cy5 and 5’-
GATAGGACTCATCACCA-3’ for 3’-O-tert-butyldithiomethyl-dUTP-5-SS-R6G),  1× 
ThermoPol reaction buffer (New England BioLabs, MA), 2 unit Therminator™ IX DNA 
polymerase (New England BioLabs, MA) and deionized H2O in a total volume of 20 µL. Reactions 
were conducted in a thermal cycler (MJ Research, MA). The extension reaction consisted of an 
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initial incubation at 94 °C for 20 sec, followed by 36 cycles at 80°C for 20 sec, 45°C for 40 sec, 
and 65°C for 90 sec. The DNA products were desalted using an Oligo Clean & Concentrator™ 
(Zymo Research, CA) and a small amount of product was analyzed by MALDI-TOF MS (ABI 
Voyager, DE). 
The remaining DNA product was concentrated under vacuum and purified by reverse phase 
HPLC on an XTerra MS C18, 2.5 µm 4.6 mm x 50 mm column (Waters, MA) to obtain the pure 
extension products. Mobile phase: A, 8.6 mM triethylamine/100 mM 1,1,1,3,3,3-hexafluoro-2-
propanol in water (pH 8.1); B, methanol. Elution was performed at 40 °C with a 0.5 mL/min flow 
rate, and from 88% A/12% B to 65.5% A /34.5% B linear gradient for 90 min.  100 pmol extension 
product was then dissolved in 10 µL 5mM tris(2-hydroxypropyl)phosphine (THP) solution (pH 5 
9.0). The mixture was incubated at 65 °C for 3 minutes, followed by dilution in 1 mL deionized 
water and desalting in an Amicon Ultra-0.5 centrifugal filter unit with Ultracel-3 membrane 
(Millipore). 2 µL DNA product were used to characterize the molecular weight information by 
MALDI-TOF mass spectrometry. The scheme is shown in Figure 3-6. 
 
3.6.4 Four-color SBS on Surface-Immobilized DNA with 3’-O-tert-Butyldithiomethyl-
dNTP and 3’-O-tert-Butyldithiomethyl-dNTP-SS-Dye Analogues 
Construction of a Chip with Immobilized Self-Priming DNA  
Slides with immobilized self-priming DNA template were constructed as illustrated in 
Figure 3-8. A self-priming template was selected such that the dissociation of the primers, as 
would could occur with linear template and primers, is avoided during the process of SBS. 5’-
amino modified self-priming template DNA (5’-CACTCACATATGTTTTTTAGCTTTTTTA 
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ATTTCTTAATGATGTTGTTGCATGCTGACCTCAGCTGCACGTAAGTGCAGCTGAGGT
CAG-3’) was dissolved in 50 mM sodium phosphate buffer, pH 9.0, at a concentration of 30 µM 
and spotted on NHS ester-5 activated CodeLink slides (Surmodics Inc., MN) using a SpotArray 
72 microarray-printing robot (PerkinElmer, MA). To immobilize the DNA, the slides were 
incubated in a humid chamber containing a solution of saturated sodium chloride at 37°C overnight, 
followed by incubation in a solution of 50 mM 3-amino-1-propanol in 100 mM tris-HCl buffer, 
pH9.0 for 2 hours at room temperature to quench unreacted NHS ester groups. The slide was then 






Figure 3-14 Construction of a lab scale SBS system. A 
HybriWell Sealing System was mounted on slides with surface-
immobilized DNA to provide homogeneous reaction conditions for 
all spots on the array 
 
A HybriWell Sealing System (Cat. 611104, Grace Bio-Labs, OR) was mounted on the glass 
slide with surface-immobilized self-primed DNA as illustrated in Figure 3-14. Compared with 
using an 8-well silicone isolator, this sealing system provides strictly uniform and identical 
reaction conditions across the spot arrays. Moreover, the boundary of each spot does not suffer 
from erosion due to the repeated attachment and removal of the isolators. 
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Extension with 3’-O-tert-Butyldithiomethyl-dNTP-SS-Dye. A HybriWell Sealing 
System was mounted on the glass slide with surface-immobilized self-primed DNA prepared as 
described previously. A 50µL solution consisting of a mixture of four chemically cleavable 
fluorescent nucleotide reversible terminators including 3’-O-tert-butyldithiomethyl-dATP-7-SS-
ROX, 3’-O-tert-butyldithiomethyl-dCTP-5-SS-Alexa488, 3’-O-tert-butyldithiomethyl-dGTP-7-
SS-Cy5 and 3’-O-tert-butyldithiomethyl-dUTP-5-SS-R6G, 0.1 U/ µL Therminator IX DNA 
polymerase (New England BioLabs, MA), 1× Thermo Pol reaction buffer (New England BioLabs, 
MA), 2 mM MnCl2, as well as deionized H2O was added into the chamber. The concentration of 
the dye mixtures starts with 12 nM for 3’-O-tert-butyldithiomethyl-dCTP-5-SS-Alexa488, 2.5 nM 
for 3’-O-tert-butyldithiomethyl-dATP-7-SS-ROX, 30 nM for 3’-O-tert-butyldithiomethyl-dUTP-
5-SS-R6G and 3 nM for 3’-O-tert-butyldithiomethyl-dGTP-7-SS-Cy5. These concentrations are 
increased proportionally every 3-5 cycles. At the end of 25 cycles, the concentration will be around 
50 folder higher, with 600 nM for 3’-O-tert-butyldithiomethyl-dCTP-5-SS-Alexa488, 125 nM for 
3’-O-tert-butyldithiomethyl-dATP-7-SS-ROX, 1500 nM for 3’-O-tert-butyldithiomethyl-dUTP-
5-SS-R6G and 150 nM for 3’-O-tert-butyldithiomethyl-dGTP-7-SS-Cy5. The reaction mixture 
was incubated at 65 °C for 15 minutes. The HybriWell Sealing System was then removed. The 
slide was rinse with Milli-Q water and immersed in SPSC buffer (1X PBS pH 7.4, 0.5 M NaCl, 
0.1% Tween-20) at 37 °C for 5 minutes. The slide was then quickly rinsed in Milli-Q water, dried 
under air, and scanned with a four-color ScanArray Express scanner (PerkinElmer Life Sciences, 
Boston, MA) to record the fluorescent signal. The laser excitation wavelengths of the scanner are 
488nm, 546nm, 594nm and 647nm. 
Chasing with 3’-O-tert-Butyldithiomethyl-dNTP. A HybriWell Sealing System was 
again mounted on the previous glass slide with surface-immobilized self-primed DNA. A solution 
 126 
(total volume of 50 µL) consisting of a chase mixture including 300 nM each of 3’-O-tert-
butyldithiomethyl-dATP, 3’-O-tert-butyldithiomethyl-dCTP, 3’-O-tert-butyldithiomethyl-dGTP 
and 3’-O-tert-butyldithiomethyl-dTTP, 0.1 U/ µL Therminator IX DNA polymerase, 1× Thermo 
Pol reaction buffer, 2 mM MnCl2, as well as deionized H2O was added into the chamber. The 
reaction mixture was incubated at 65 °C for 10 minutes. The HybriWell Sealing System was then 
removed. The slide was rinsed with Milli-Q water and immersed in SPSC buffer at 37 °C for 5 
minutes. The slide was then quickly rinsed in Milli-Q water and dried under air. 
Cleavage with Tris (3-hydroxypropyl) Phosphine (THP). A HybriWell Sealing System 
was mounted on the above glass slide. 50 µL THP Solution (5 mM tris(3-
hydroxypropyl)phosphine, 1X PBS pH 7.4) was added into the chamber.  The reaction mixture 
was incubated at 65 °C for 10 minutes. The HybriWell Sealing System was then removed. The 
slide was rinse with Milli-Q water and immersed in SPSC buffer at 37 °C for 10 minutes. The slide 
was then quickly rinsed in Milli-Q water, dried under air, and scanned with a four-color ScanArray 
Express scanner to record the fluorescent signal. The laser excitation wavelengths of the scanner 
are 488nm, 546nm, 594nm and 647nm. 
Repeat the steps. The extension, chase, and cleavage are repeated for each additional cycle. 
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